FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pier Mannucci

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Italy

Concepts & Ideas

Risk Factors

Physiology

Anatomy

Thrombosis

Co-author Network

Publications

TOP 3
Armando Tripodi; Massimo Primignani; Paolo Rebulla; Veena Chantarangkul; Manol Jovani; Laura Lemma; Pier M Mannucci
Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.
Paolo Bucciarelli; Franca Franchi; F Gianniello; Pier M Mannucci; Eugenia Biguzzi; Serena Maria Passamonti; Ida Martinelli
Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism.
Serena Maria Passamonti; D Pietra; Eugenia Biguzzi; Paolo Bucciarelli; M Cazzola; F Franchi; F Gianniello; Pier M Mannucci; Ida Martinelli
The JAK2 V617F mutation in patients with cerebral venous thrombosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pier Mannucci (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Armando Tripodi; Massimo Primignani; Paolo Rebulla; Veena Chantarangkul; Manol Jovani; Laura Lemma; Pier M Mannucci
Global hemostasis tests in patients with cirrhosis before and after prophylactic platelet transfusion.
Liver international : official journal of the International Association for the Study of the Liver 2013;33(3):362-7.
2012: Paolo Bucciarelli; Franca Franchi; F Gianniello; Pier M Mannucci; Eugenia Biguzzi; Serena Maria Passamonti; Ida Martinelli
Low borderline plasma levels of antithrombin, protein C and protein S are risk factors for venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2012;10(9):1783-91.
2012: Serena Maria Passamonti; D Pietra; Eugenia Biguzzi; Paolo Bucciarelli; M Cazzola; F Franchi; F Gianniello; Pier M Mannucci; Ida Martinelli
The JAK2 V617F mutation in patients with cerebral venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2012;10(6):998-1003.
2012: Maria Elisa Mancuso; Pier M Mannucci; Angiola Rocino; Isabella Garagiola; Annarita Tagliaferri; Elena Santagostino
Source and purity of factor VIII products as risk factors for inhibitor development in patients with hemophilia A.
Journal of thrombosis and haemostasis : JTH 2012;10(5):781-90.
2012: Sylvia von Mackensen; Alessandro Gringeri; Pier M Mannucci; Simona Maria Siboni
Health-related quality of life and psychological well-being in elderly patients with haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(3):345-52.
2012: Spero R Cataland; James C Gilbert; Bernd Jilma; Johanna A Kremer-Hovinga; Bernhard Lämmle; Samuel J Machin; Pier M Mannucci; Flora Peyvandi; Gail Rock; Marie Scully; Haifeng Wu; Shangbin Yang; Paul Knoebl
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura.
American journal of hematology 2012;87(4):430-2.
2012: Eugenia Biguzzi; Paolo Bucciarelli; Franca Franchi; Buthaina Ibrahim; Barbara Acaia; Federico Ambrogi; Elia Biganzoli; Tatjana Radaelli; Pier M Mannucci
Risk factors for postpartum hemorrhage in a cohort of 6011 Italian women.
Thrombosis research 2012;129(4):e1-7.
2012: Luca A Lotta; Pier M Mannucci; Ida Martinelli; Marzia Menegatti; Donna M Muzny; Emanuela Pappalardo; Serena M Passamonti; Humeira Akbar; Matthew N Bainbridge; Dario Consonni; Richard A Gibbs; Lora L Lewis; Steven E Scherer; Mark Wang; Yuanqing Wu; Fuli Yu; Jin Yu; Flora Peyvandi
Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes.
BMC medical genomics 2012;5():7.
2012: Simona Maria Siboni; Gianluca Sottilotta; A Tagliaferri; E Zanon; F Biondo; G Castaman; D Consonni; A Iorio; Pier M Mannucci; D Mikovic; Flora Peyvandi
Central nervous system bleeding in patients with rare bleeding disorders.
Haemophilia : the official journal of the World Federation of Hemophilia 2012;18(1):34-8.
2011: Pier M Mannucci
Factor VIII inhibitors in previously treated hemophilic patients.
Journal of thrombosis and haemostasis : JTH 2011;9(11):2328-9.
2011: Ilaria Guella; Pier M Mannucci; Pier Angelica Merlini; Flora Peyvandi; Diego Ardissino; Stefano Duga; Rosanna Asselta
Common variants in the haemostatic gene pathway contribute to risk of early-onset myocardial infarction in the Italian population.
Thrombosis and haemostasis 2011;106(4):655-64.
2011: Augusto B Federici; Alfonso Iorio; Luciano Baronciani; Paolo Bucciarelli; Maria T Canciani; Giancarlo Castaman; Maria G Mazzucconi; Massimo Morfini; Emily Oliovecchio; Angiola Rocino; Mario Schiavoni; Pier M Mannucci
Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients.
Seminars in thrombosis and hemostasis 2011;37(5):511-21.
2011: Alessandro Gringeri; B Lundin; Sylvia von Mackensen; L Mantovani; Pier M Mannucci
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study).
Journal of thrombosis and haemostasis : JTH 2011;9(4):700-10.
2011: Armando Tripodi; M Primignani; Veena Chantarangkul; Pier M Mannucci
More on: enhanced thrombin generation in patients with cirrhosis-induced coagulopathy.
Journal of thrombosis and haemostasis : JTH 2011;9(3):612-3; author reply 613-14.
2010: M Marcucci; A Iorio; Alessandro Nobili; M Tettamanti; L Pasina; A Marengoni; F Salerno; salvatore corrao; Pier M Mannucci
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards.
European journal of internal medicine 2010;21(6):516-23.
2010: Valentina Cipriani; Pier M Mannucci; Diego Ardissino; Maurizio Ferrario; Giancarlo Corsini; Piera Angelica Merlini; Francesca Notarangelo; Daniela Lina; Luisa Bernardinelli
Familial aggregation of early-onset myocardial infarction.
European journal of internal medicine 2010;21(6):511-5.
2010: Luca A Lotta; Mariagabriella Mariani; Dario Consonni; Ilaria Mancini; Roberta Palla; Alberto Maino; Dragica Vucelic; Michele Pizzuti; Pier M Mannucci; Flora Peyvandi
Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura.
British journal of haematology 2010;151(5):488-94.
2010: Ida Martinelli; P Bucciarelli; Valerio De Stefano; S M Passamonti; M Menegatti; D Tormene; Alberto Tosetto; Pier M Mannucci
Effect of prothrombin 19911 A>G polymorphism on the risk of cerebral sinus-venous thrombosis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2010;17(12):1482-5.
2010: Pier M Mannucci; Rosanna Asselta; Stefano Duga; I Guella; Marta Spreafico; L Lotta; P A Merlini; Flora Peyvandi; Sekar Kathiresan; D Ardissino
The association of factor V Leiden with myocardial infarction is replicated in 1880 patients with premature disease.
Journal of thrombosis and haemostasis : JTH 2010;8(10):2116-21.
2010: Flora Peyvandi; M J Hollestelle; R Palla; P A Merlini; H B Feys; K Vanhoorelbeke; P J Lenting; Pier M Mannucci
Active platelet-binding conformation of plasma von Willebrand factor in young women with acute myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2010;8(7):1653-6.
2010: Pier M Mannucci; E P Mauser-Bunschoten
Cardiovascular disease in haemophilia patients: a contemporary issue.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16 Suppl 3():58-66.
2010: Pier M Mannucci
Fine particulate: it matters.
Journal of thrombosis and haemostasis : JTH 2010;8(4):659-61.
2010: Elena Santagostino; Maria Elisa Mancuso; Armando Tripodi; Veena Chantarangkul; Marigrazia Clerici; Isabella Garagiola; Pier M Mannucci
Severe hemophilia with mild bleeding phenotype: molecular characterization and global coagulation profile.
Journal of thrombosis and haemostasis : JTH 2010;8(4):737-43.
2010: Augusto B Federici; G Barillari; E Zanon; M G Mazzucconi; R Musso; R Targhetta; Pier M Mannucci
Efficacy and safety of highly purified, doubly virus-inactivated VWF/FVIII concentrates in inherited von Willebrand's disease: results of an Italian cohort study on 120 patients characterized by bleeding severity score.
Haemophilia : the official journal of the World Federation of Hemophilia 2010;16(1):101-10.
2009: Pier M Mannucci; Roger Schutgens; Elena Santagostino; Evelien P Mauser-Bunschoten
How I treat age-related morbidities in elderly persons with hemophilia.
Blood 2009;114(26):5256-63.
2009: Maria Elisa Mancuso; M G Rumi; A Aghemo; Elena Santagostino; M Puoti; Antonio Coppola; M Colombo; Pier M Mannucci
Hepatitis C virus/human immunodeficiency virus coinfection in hemophiliacs: high rates of sustained virologic response to pegylated interferon and ribavirin therapy.
Journal of thrombosis and haemostasis : JTH 2009;7(12):1997-2005.
2009: Armando Tripodi; Veena Chantarangkul; Pier M Mannucci
Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing.
British journal of haematology 2009;147(1):77-82.
2009: Pier M Mannucci; Augusto B Federici; A H James; C M Kessler
von Willebrand disease in the 21st century: current approaches and new challenges.
Haemophilia : the official journal of the World Federation of Hemophilia 2009;15(5):1154-8.
2009: Flora Peyvandi; Luca A Lotta; Pier M Mannucci
Inhibitors of factor VIII in hemophilia.
The New England journal of medicine 2009;361(3):309; author reply 310.
2009: Luciano Baronciani; Augusto B Federici; M Punzo; M Solimando; Guido Cozzi; S La Marca; V Rubini; Maria Teresa Canciani; Pier M Mannucci
Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization.
Journal of thrombosis and haemostasis : JTH 2009;7(7):1114-22.
2009: Armando Tripodi; Cristina Legnani; G Palareti; Veena Chantarangkul; Pier M Mannucci
More on: high thrombin generation and the risk of recurrent venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2009;7(5):906-7.
2009: Simona Maria Siboni; Pier M Mannucci; Alessandro Gringeri; M Franchini; Annarita Tagliaferri; Marzia Ferretti; F Tradati; Elena Santagostino; Sylvia von Mackensen
Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy.
Journal of thrombosis and haemostasis : JTH 2009;7(5):780-6.
2009: Eugenia Biguzzi; Patrizia Mancuso; Franca Franchi; Angelica Calleri; Maria Elisa Mancuso; Elena Santagostino; Paolo Bucciarelli; Francesco Bertolini; Pier M Mannucci
Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype.
British journal of haematology 2009;144(5):803-5.
2009: Augusto B Federici; Pier M Mannucci; Giancarlo Castaman; Luciano Baronciani; Paolo Bucciarelli; Maria Teresa Canciani; Alessandro Pecci; Peter J Lenting; Philip G de Groot
Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients.
Blood 2009;113(3):526-34.
2008: Uwe Kalina; Hans-Arnold Stöhr; Heike Bickhard; Sigurd Knaub; Simona M Siboni; Pier M Mannucci; Flora Peyvandi
Rotational thromboelastography for monitoring of fibrinogen concentrate therapy in fibrinogen deficiency.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2008;19(8):777-83.
2008: Marta Spreafico; Corrado Lodigiani; Y van Leeuwen; Denise Pizzotti; Lidia L Rota; Fr Rosendaal; Pier M Mannucci; Flora Peyvandi
Effects of CYP2C9 and VKORC1 on INR variations and dose requirements during initial phase of anticoagulant therapy.
Pharmacogenomics 2008;9(9):1237-50.
2008: Armando Tripodi; Flora Peyvandi; Veena Chantarangkul; R Palla; A Afrasiabi; Maria Teresa Canciani; D W Chung; S Ferrari; Y Fujimura; M Karimi; K Kokame; J A Kremer Hovinga; B Lämmle; S F de Meyer; B Plaimauer; Karen Vanhoorelbeke; K Varadi; Pier M Mannucci
Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13).
Journal of thrombosis and haemostasis : JTH 2008;6(9):1534-41.
2008: Pier M Mannucci; Marta Spreafico; Flora Peyvandi
Dosing anticoagulant therapy with coumarin drugs: is genotyping clinically useful? No.
Journal of thrombosis and haemostasis : JTH 2008;6(9):1450-2.
2008: Armando Tripodi; Cristina Legnani; Veena Chantarangkul; B Cosmi; G Palareti; Pier M Mannucci
High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2008;6(8):1327-33.
2008: Pier M Mannucci
Back to the future: a recent history of haemophilia treatment.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 3():10-8.
2008: Pier M Mannucci; Marta Spreafico; Flora Peyvandi
Genetics of warfarin response.
The New England journal of medicine 2008;358(25):2743; author reply 2743-4.
2008: Erik Berntorp; William Archey; Günter Auerswald; Augusto B Federici; Massimo Franchini; Sigurd Knaub; Wolfhart Kreuz; Stefan Lethagen; Pier M Mannucci; Hartmut Pollmann; Inge Scharrer; Keith Hoots
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate P/ Humate -P: history and clinical performance.
European journal of haematology. Supplementum 2008;(70):3-35.
2008: Luciano Baronciani; Augusto B Federici; Giovanna Cozzi; S La Marca; M Punzo; V Rubini; Maria Teresa Canciani; Pier M Mannucci
Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(3):549-55.
2008: Gaetano M Bergamaschi; Massimo Primignani; Giovanni Barosi; Federica M Fabris; Laura Villani; Raffaella Reati; Alessandra Dell'era; Pier M Mannucci
MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction.
Blood 2008;111(8):4418.
2008: Ida Martinelli; Tullia Battaglioli; Valerio De Stefano; D Tormene; L Valdrè; E Grandone; Alberto Tosetto; Pier M Mannucci
The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
Journal of thrombosis and haemostasis : JTH 2008;6(3):494-8.
2008: Armando Tripodi; Veena Chantarangkul; Pier M Mannucci
The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions.
Journal of thrombosis and haemostasis : JTH 2008;6(2):243-8.
2008: Pier M Mannucci
Desmopressin: an historical introduction.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14 Suppl 1():1-4.
2008: Augusto B Federici; Pier M Mannucci; P Marco
Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.
Haemophilia : the official journal of the World Federation of Hemophilia 2008;14(1):133-9.
2007: Pier M Mannucci; Alessandro Gringeri; Flora Peyvandi; Elena Santagostino
Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers).
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13 Suppl 5():65-8.
2007: Pier Luigi Meroni; Flora Peyvandi; Luisa Foco; Luisa Bernardinelli; R Fetiveau; Pier M Mannucci; Angela Tincani
Anti-beta 2 glycoprotein I antibodies and the risk of myocardial infarction in young premenopausal women.
Journal of thrombosis and haemostasis : JTH 2007;5(12):2421-8.
2007: Fabiola B Sozzi; Gian Battista Danzi; Luisa Foco; Marco Ferlini; Marco Tubaro; Michele Galli; Patrizia Celli; Pier M Mannucci
Myocardial infarction in the young: a sex-based comparison.
Coronary artery disease 2007;18(6):429-31.
2007: Hendrik Feys; Maria Teresa Canciani; Flora Peyvandi; Hans Deckmyn; Karen Vanhoorelbeke; Pier M Mannucci
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis.
British journal of haematology 2007;138(4):534-40.
2007: Pier M Mannucci
Thrombosis and bleeding disorders outside Western countries.
Journal of thrombosis and haemostasis : JTH 2007;5 Suppl 1():68-72.
2007: Alessandro Gringeri; Roberto Musso; Maria Gabriella Mazzucconi; G Piseddu; Mario Schiavoni; P Pignoloni; Pier M Mannucci
Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
Haemophilia : the official journal of the World Federation of Hemophilia 2007;13(4):373-9.
2007: R Sacco; M Sacco; M Carpenedo; Pier M Mannucci
Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different intensity targets.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2007;104(1):e18-21.
2007: Luciano Baronciani; Augusto B Federici; Giovanna Cozzi; Maria Teresa Canciani; Pier M Mannucci
Biochemical characterization of a recombinant von Willebrand factor (VWF) with combined type 2B and type 1 defects in the VWF gene in two patients with a type 2A phenotype of von Willebrand disease.
Journal of thrombosis and haemostasis : JTH 2007;5(2):282-8.
2007: Ida Martinelli; Tullia Battaglioli; Cristina Razzari; Pier M Mannucci
Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
Journal of thrombosis and haemostasis : JTH 2007;5(1):98-101.
2006: Ida Martinelli; Tullia Battaglioli; Alberto Tosetto; Cristina Legnani; L Sottile; Rossella Ghiotto; Pier M Mannucci
Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2006;4(12):2582-6.
2006: Luciano Baronciani; Augusto B Federici; Giovanna Cozzi; Maria Teresa Canciani; Pier M Mannucci
von Willebrand factor collagen binding assay in von Willebrand disease type 2A, 2B, and 2M.
Journal of thrombosis and haemostasis : JTH 2006;4(9):2088-90.
2006: Pier M Mannucci; Thomas C Abshire; Donna DiMichele; Elena Santagostino; V Blanchette
Inhibitor development, immune tolerance and prophylaxis in haemophilia A--the need for an evidence-based approach.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(4):429-34.
2006: Flora Peyvandi; Randal J Kaufman; U Seligsohn; O Salomon; Paula H B Bolton-Maggs; Marta Spreafico; Marzia Menegatti; Roberta Palla; Simona Maria Siboni; Pier M Mannucci
Rare bleeding disorders.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12 Suppl 3():137-42.
2006: Flora Peyvandi; Giridhara Rao Jayandharan; Mammen Chandy; Alok Srivastava; Shelley M Nakaya; M J Johnson; Arthur R Thompson; A Goodeve; Isabella Garagiola; Silvia Lavoretano; Marzia Menegatti; Roberta Palla; Marta Spreafico; Luca Tagliabue; Rosanna Asselta; Stefano Duga; Pier M Mannucci
Genetic diagnosis of haemophilia and other inherited bleeding disorders.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12 Suppl 3():82-9.
2006: Armando Tripodi; Veena Chantarangkul; Daniela Asti; Ida Martinelli; Pier M Mannucci
Activated partial thromboplastin time: results of a case-control study evaluating six commercial reagents in assessing the risk of venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2006;4(6):1407-9.
2006: Pier M Mannucci
Assessing the risk of inhibitor formation with different factor VIII products.
Blood 2006;107(9):3809-10; author reply 3810.
2006: Pier M Mannucci
Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No.
Journal of thrombosis and haemostasis : JTH 2006;4(4):721-3.
2006: Augusto B Federici; Elena Santagostino; Maria Grazia Rumi; Antonio Russo; Maria Elisa Mancuso; Roberta Soffredini; Pier M Mannucci; Massimo Colombo
The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study.
Haematologica 2006;91(4):503-8.
2006: Luciana Scalone; Lorenzo Giovanni Mantovani; Pier M Mannucci; Alessandro Gringeri
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(2):154-62.
2006: Alessandro Gringeri; mara silvia monzini; Giuseppe Tagariello; FA Scaraggi; Pier M Mannucci
Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
Haemophilia : the official journal of the World Federation of Hemophilia 2006;12(2):128-32.
2006: Pier M Mannucci
Need for randomized trials in hemophilia.
Journal of thrombosis and haemostasis : JTH 2006;4(3):501-2.
2006: Elena Santagostino; Maria Elisa Mancuso; Angiola Rocino; Giacomo Mancuso; FA Scaraggi; Pier M Mannucci
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors.
Journal of thrombosis and haemostasis : JTH 2006;4(2):367-71.
2005: Ida Martinelli; Cristina Razzari; Eugenia Biguzzi; Paolo Bucciarelli; Pier M Mannucci
Low levels of protein Z and the risk of venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2817-9.
2005: Pier M Mannucci
Thrombolytic therapy in acute myocardial infarction.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2806-7.
2005: Luciano Baronciani; Augusto B Federici; Mario Beretta; Giovanna Cozzi; Maria Teresa Canciani; Pier M Mannucci
Expression studies on a novel type 2B variant of the von Willebrand factor gene (R1308L) characterized by defective collagen binding.
Journal of thrombosis and haemostasis : JTH 2005;3(12):2689-94.
2005: Pier M Mannucci
Management of von Willebrand disease in developing countries.
Seminars in thrombosis and hemostasis 2005;31(5):602-9.
2005: Alessandro Gringeri; Pier M Mannucci
Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(6):611-9.
2005: Lorenzo Giovanni Mantovani; mara silvia monzini; Pier M Mannucci; Luciana Scalone; M Villa; Alessandro Gringeri
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia: a discrete choice experiment.
Haemophilia : the official journal of the World Federation of Hemophilia 2005;11(6):589-97.
2005: Flora Peyvandi; Isabella Garagiola; Roberta Palla; N Marziliano; Pier M Mannucci
Role of the 2 adenine (g.11293_11294insAA) insertion polymorphism in the 3' untranslated region of the factor VII (FVII) gene: molecular characterization of a patient with severe FVII deficiency.
Human mutation 2005;26(5):455-61.
2005: Pier M Mannucci
Laboratory detection of inherited thrombophilia: a historical perspective.
Seminars in thrombosis and hemostasis 2005;31(1):5-10.
2005: Pier M Mannucci; Luisa Bernardinelli; Luisa Foco; M Galli; F Ribichini; Marco Tubaro; Flora Peyvandi
Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women.
Journal of thrombosis and haemostasis : JTH 2005;3(2):280-6.
2005: Pier M Mannucci
von Willebrand factor: a prima ballerina on two different stages.
Seminars in hematology 2005;42(1):1-4.
2005: Sepideh Akhavan; Maria A Miteva; Bruno Villoutreix; Laurence Venisse; Flora Peyvandi; Pier M Mannucci; Marie-Claude Guillin; Annie Bezeaud
A critical role for Gly25 in the B chain of human thrombin.
Journal of thrombosis and haemostasis : JTH 2005;3(1):139-45.
2004: zahrai zahra; Flora Peyvandi; Simona Maria Siboni; R Ardeshiri; A Gringeri; Pier M Mannucci
Comparison of attitudes towards prenatal diagnosis and termination of pregnancy for haemophilia in Iran and Italy.
Haemophilia : the official journal of the World Federation of Hemophilia 2004;10(4):367-9.
2004: Elena Santagostino; F De Filippi; Maria Grazia Rumi; Monica Rivi; Massimo Colombo; Pier M Mannucci
Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult hemophilic patients.
Transfusion 2004;44(5):790-4.
2004: Augusto B Federici; Claudine Mazurier; Erik Berntorp; Christine A Lee; Inge Scharrer; Jenny Goudemand; Stephan Lethagen; Ioana Nitu; Gerard Ludwig; Lysiane Hilbert; Pier M Mannucci
Biologic response to desmopressin in patients with severe type 1 and type 2 von Willebrand disease: results of a multicenter European study.
Blood 2004;103(6):2032-8.
2004: A Srámek; Paolo Bucciarelli; Augusto B Federici; Pier M Mannucci; V De Rosa; Giancarlo Castaman; Massimo Morfini; Maria Gabriella Mazzucconi; Angiola Rocino; Mario Schiavoni; FA Scaraggi; Johan H C Reiber; Frits R Rosendaal
Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis: results from a multicenter study in 47 patients.
Circulation 2004;109(6):740-4.
2003: Marta Spreafico; Flora Peyvandi; D Pizzotti; Marco Moia; Pier M Mannucci
Warfarin and acenocoumarol dose requirements according to CYP2C9 genotyping in North-Italian patients.
Journal of thrombosis and haemostasis : JTH 2003;1(10):2252-3.
2003: Pier M Mannucci
AIDS, hepatitis and hemophilia in the 1980s: memoirs from an insider.
Journal of thrombosis and haemostasis : JTH 2003;1(10):2065-9.
2003: Pier M Mannucci
Consistency of ADAMTS-13 activity assays: a moderately optimistic view.
Journal of thrombosis and haemostasis : JTH 2003;1(9):1880-1.
2003: Pier M Mannucci; Diego Ardissino; Piera Angelica Merlini; Flora Peyvandi
Vagaries of genetic association studies in myocardial infarction.
Blood 2003;102(4):1558-9; author reply 1559-60.
2003: Ida Martinelli; Tullia Battaglioli; Paola Pedotti; Marco Cattaneo; Pier M Mannucci
Hyperhomocysteinemia in cerebral vein thrombosis.
Blood 2003;102(4):1363-6.
2003: Manijeh Lak; Flora Peyvandi; A Ali Sharifian; K Karimi; Pier M Mannucci
Pattern of symptoms in 93 Iranian patients with severe factor XIII deficiency.
Journal of thrombosis and haemostasis : JTH 2003;1(8):1852-3.
2003: Pier M Mannucci
Hemophilia: treatment options in the twenty-first century.
Journal of thrombosis and haemostasis : JTH 2003;1(7):1349-55.
2003: Rosanna Asselta; Maria Claudia Montefusco; Stefano Duga; Massimo Malcovati; Flora Peyvandi; Pier M Mannucci; Maria Luisa Tenchini
Severe factor V deficiency: exon skipping in the factor V gene causing a partial deletion of the C1 domain.
Journal of thrombosis and haemostasis : JTH 2003;1(6):1237-44.
2003: A M Randi; Eugenia Biguzzi; Francesco Falciani; Piera Angelica Merlini; S Blakemore; Ezio Bramucci; Stefano Lucreziotti; M Lennon; Elena M Faioni; D Ardissino; Pier M Mannucci
Identification of differentially expressed genes in coronary atherosclerotic plaques from patients with stable or unstable angina by cDNA array analysis.
Journal of thrombosis and haemostasis : JTH 2003;1(4):829-35.
2003: Pier M Mannucci
Desmopressin (DDAVP) and factor VIII: the tale as viewed from Milan (and Malmö).
Journal of thrombosis and haemostasis : JTH 2003;1(4):622-4.
2003: Pier M Mannucci; Flora Peyvandi; Diego Ardissino
Risk of myocardial infarction and polymorphisms in candidate genes.
The New England journal of medicine 2003;348(12):1176-7; author reply 1176-7.
2003: Pier M Mannucci
Treatment of hemophilia: recombinant factors only? No.
Journal of thrombosis and haemostasis : JTH 2003;1(2):216-7.
2003: Pier M Mannucci
Overview of bleeding in cancer patients.
Pathophysiology of haemostasis and thrombosis 2003;33 Suppl 1():44-5.
2002: Flora Peyvandi; Marta Spreafico; M Karimi; Sirous Zeinali; Pier M Mannucci; A Bianchi Bonomi
Allele frequency of CYP2C9 gene polymorphisms in Iran.
Thrombosis and haemostasis 2002;88(5):874-5.
2002: Pier M Mannucci
Venous thrombosis: the history of knowledge.
Pathophysiology of haemostasis and thrombosis 2002;32(5-6):209-12.
2002: Pier M Mannucci
Venous thromboembolism in von Willebrand disease.
Thrombosis and haemostasis 2002;88(3):378-9.
2002: Augusto B Federici; Giancarlo Castaman; Pier M Mannucci
Guidelines for the diagnosis and management of von Willebrand disease in Italy.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(5):607-21.
2002: Sepideh Akhavan; Raimondo De Cristofaro; Flora Peyvandi; Silvia Lavoretano; Raffaele Landolfi; Pier M Mannucci
Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype.
Blood 2002;100(4):1347-53.
2002: Pier M Mannucci
The measurement of multifactorial thrombophilia.
Thrombosis and haemostasis 2002;88(1):1-2.
2002: Ida Martinelli; Paolo Bucciarelli; Maddalena L Zighetti; Anna Maria Cafro; Pier M Mannucci
Low risk of thrombosis in family members of patients with hyperhomocysteinaemia.
British journal of haematology 2002;117(3):709-11.
2002: Flora Peyvandi; Marzia Menegatti; Elena Santagostino; Sepideh Akhavan; James Uprichard; David J Perry; Stephen J Perkins; Pier M Mannucci
Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency.
British journal of haematology 2002;117(3):685-92.
2002: Flora Peyvandi; Stefano Duga; Sepideh Akhavan; Pier M Mannucci
Rare coagulation deficiencies.
Haemophilia : the official journal of the World Federation of Hemophilia 2002;8(3):308-21.
2002: Pier M Mannucci; Juan Chediak; Wahid Hanna; John Byrnes; Marlies Ledford; Bruce M Ewenstein; Anastassios Retzios; Barbara A Kapelan; Richard S Schwartz; Craig Kessler
Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study.
Blood 2002;99(2):450-6.
2002: Pier M Mannucci
Hemophilia and related bleeding disorders: a story of dismay and success.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():1-9.
2002: Elena Santagostino; Alessandro Gringeri; Pier M Mannucci
State of care for hemophilia in pediatric patients.
Paediatric drugs 2002;4(3):149-57.
2001: Rosanna Asselta; Stefano Duga; Silvia Spena; Elena Santagostino; Flora Peyvandi; G Piseddu; R Targhetta; Massimo Malcovati; Pier M Mannucci; Maria Luisa Tenchini
Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs.
Blood 2001;98(13):3685-92.
2001: Flora Peyvandi; Rosanna Asselta; Pier M Mannucci
Autosomal recessive deficiencies of coagulation factors.
Reviews in clinical and experimental hematology 2001;5(4):369-88.
2001: Armando Tripodi; Veena Chantarangkul; Marigrazia Clerici; B Negri; M Galli; Pier M Mannucci
Laboratory control of oral anticoagulant treatment by the INR system in patients with the antiphospholipid syndrome and lupus anticoagulant. Results of a collaborative study involving nine commercial thromboplastins.
British journal of haematology 2001;115(3):672-8.
2001: Pier M Mannucci
Venous thromboembolism and hormone replacement therapy.
European journal of internal medicine 2001;12(6):478-83.
2001: Marco Cattaneo; Rossana Lombardi; Anna Lecchi; Paolo Bucciarelli; Pier M Mannucci
Low plasma levels of vitamin B(6) are independently associated with a heightened risk of deep-vein thrombosis.
Circulation 2001;104(20):2442-6.
2001: Pier M Mannucci; Maria Teresa Canciani; Ileana Forza; Federico Lussana; A Lattuada; E Rossi
Changes in health and disease of the metalloprotease that cleaves von Willebrand factor.
Blood 2001;98(9):2730-5.
2001: Diego Ardissino; Piera Angelica Merlini; K A Bauer; Ezio Bramucci; Maurizio Ferrario; R Coppola; Raffaela Fetiveau; Stefano Lucreziotti; R D Rosenberg; Pier M Mannucci
Thrombogenic potential of human coronary atherosclerotic plaques.
Blood 2001;98(9):2726-9.
2001: Eugenia Biguzzi; Giuliana Merati; PC Liaw; Paolo Bucciarelli; Natalia Oganesyan; Dongfeng Qu; Jian-Ming Gu; R Fetiveau; Charles T Esmon; Pier M Mannucci; Elena M Faioni
A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function.
Thrombosis and haemostasis 2001;86(4):945-8.
2001: Ida Martinelli; Cristina Legnani; Paolo Bucciarelli; E Grandone; Valerio De Stefano; Pier M Mannucci
Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Thrombosis and haemostasis 2001;86(3):800-3.
2001: Richard van Wijk; Maria Claudia Montefusco; Stefano Duga; Rosanna Asselta; Wouter W van Solinge; Massimo Malcovati; Maria Luisa Tenchini; Pier M Mannucci
Coexistence of a novel homozygous nonsense mutation in exon 13 of the factor V gene with the homozygous Leiden mutation in two unrelated patients with severe factor V deficiency.
British journal of haematology 2001;114(4):871-4.
2001: Armando Tripodi; Pier M Mannucci
Laboratory investigation of thrombophilia.
Clinical chemistry 2001;47(9):1597-606.
2001: Marzia Menegatti; Rosanna Asselta; Stefano Duga; Massimo Malcovati; Paolo Bucciarelli; Pier M Mannucci; Maria Luisa Tenchini
Identification of four novel polymorphisms in the Aalpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein.
Thrombosis research 2001;103(4):299-307.
2001: Pier M Mannucci; L Poller
Venous thrombosis and anticoagulant therapy.
British journal of haematology 2001;114(2):258-70.
2001: Pier M Mannucci
Treatment of von Willebrand disease.
Thrombosis and haemostasis 2001;86(1):149-53.
2001: Pier M Mannucci
Genetic hypercoagulability: prevention suggests testing family members.
Blood 2001;98(1):21-2.
2001: Pier M Mannucci; E G Tuddenham
The hemophilias--from royal genes to gene therapy.
The New England journal of medicine 2001;344(23):1773-9.
2001: Pier M Mannucci; Augusto B Federici
Management of inherited von Willebrand disease.
Best practice & research. Clinical haematology 2001;14(2):455-62.
2001: A Tripodi; Veena Chantarangkul; Pier M Mannucci
Near-patient testing devices to monitor oral anticoagulant therapy.
British journal of haematology 2001;113(4):847-52.
2001: Pier M Mannucci
How I treat patients with von Willebrand disease.
Blood 2001;97(7):1915-9.
2001: Armando Tripodi; Veena Chantarangkul; Rossana Lombardi; Anna Lecchi; Pier M Mannucci; Marco Cattaneo
Multicenter study of homocysteine measurement--performance characteristics of different methods, influence of standards on interlaboratory agreement of results.
Thrombosis and haemostasis 2001;85(2):291-5.
2001: Pier M Mannucci
Autoimmune bleeding disorders in cancer patients.
Haemostasis 2001;31 Suppl 1():45-6.
2001: Augusto B Federici; Jacob H Rand; Pier M Mannucci
Acquired von Willebrand syndrome: an important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(6):358-62.
2001: Pier M Mannucci; L Mendolicchio; Alessandro Gringeri
Use of prophylaxis to prevent complications of hemophilia.
Advances in experimental medicine and biology 2001;489():59-64.
2000: Maria Claudia Montefusco; Stefano Duga; Rosanna Asselta; Elena Santagostino; Giacomo Mancuso; Massimo Malcovati; Pier M Mannucci; Maria Luisa Tenchini
A novel two base pair deletion in the factor V gene associated with severe factor V deficiency.
British journal of haematology 2000;111(4):1240-6.
2000: Manijeh Lak; Flora Peyvandi; Pier M Mannucci
Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von Willebrand disease.
British journal of haematology 2000;111(4):1236-9.
2000: Ida Martinelli; Paolo Bucciarelli; Maurizio Margaglione; Valerio De Stefano; Giancarlo Castaman; Pier M Mannucci
The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both.
British journal of haematology 2000;111(4):1223-9.
2000: Sepideh Akhavan; Pier M Mannucci; Manijeh Lak; G Mancuso; Maria Gabriella Mazzucconi; Angiola Rocino; P Vincent Jenkins; Stephen J Perkins
Identification and three-dimensional structural analysis of nine novel mutations in patients with prothrombin deficiency.
Thrombosis and haemostasis 2000;84(6):989-97.
2000: Ida Martinelli; Emanuela Taioli; Irene Cetin; A Marinoni; S Gerosa; M V Villa; Maddalena Bozzo; Pier M Mannucci
Mutations in coagulation factors in women with unexplained late fetal loss.
The New England journal of medicine 2000;343(14):1015-8.
2000: Luciano Baronciani; Giovanna Cozzi; Maria Teresa Canciani; Flora Peyvandi; A Srivastava; Augusto B Federici; Pier M Mannucci
Molecular characterization of a multiethnic group of 21 patients with type 3 von Willebrand disease.
Thrombosis and haemostasis 2000;84(4):536-40.
2000: Rosanna Asselta; Stefano Duga; Tatjana Simonic; Massimo Malcovati; Elena Santagostino; P L Giangrande; Pier M Mannucci; Maria Luisa Tenchini
Afibrinogenemia: first identification of a splicing mutation in the fibrinogen gamma chain gene leading to a major gamma chain truncation.
Blood 2000;96(7):2496-500.
2000: Flora Peyvandi; P Vincent Jenkins; Pier M Mannucci; A Billio; Sirous Zeinali; Stephen J Perkins; David J Perry
Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency.
Thrombosis and haemostasis 2000;84(2):250-7.
2000: Pier M Mannucci
Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years.
Haemophilia : the official journal of the World Federation of Hemophilia 2000;6 Suppl 1():60-7.
2000: A Tripodi; Veena Chantarangkul; Valerio De Stefano; Pier M Mannucci
Alpha(2)-macroglobulin levels are high in adult patients with congenital antithrombin deficiency.
Thrombosis research 2000;98(2):117-22.
2000: Augusto B Federici; R Sacco; F Stabile; M Carpenedo; E Zingaro; Pier M Mannucci
Optimising local therapy during oral surgery in patients with von Willebrand disease: effective results from a retrospective analysis of 63 cases.
Haemophilia : the official journal of the World Federation of Hemophilia 2000;6(2):71-7.
2000: Diego Ardissino; Piera Angelica Merlini; R Arlens; R Coppola; Ezio Bramucci; Stefano Lucreziotti; Alessandra Repetto; Raffaela Fetiveau; Pier M Mannucci
Tissue factor in human coronary atherosclerotic plaques.
Clinica chimica acta; international journal of clinical chemistry 2000;291(2):235-40.
2000: Stefano Duga; Rosanna Asselta; Elena Santagostino; Sirous Zeinali; Tatjana Simonic; Massimo Malcovati; Pier M Mannucci; Maria Luisa Tenchini
Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion.
Blood 2000;95(4):1336-41.
2000: Sirous Zeinali; F Duca; B Zarbakhsh; Luca Tagliabue; Pier M Mannucci
Thrombophilic mutations in Iran.
Thrombosis and haemostasis 2000;83(2):351-2.
2000: Elena M Faioni; J Hermida; Ermanna Rovida; Cristina Razzari; Daniela Asti; Sirous Zeinali; Pier M Mannucci
Type II protein C deficiency: identification and molecular modelling of two natural mutants with low anticoagulant and normal amidolytic activity.
British journal of haematology 2000;108(2):265-71.
2000: Flora Peyvandi; Pier M Mannucci; Paolo Bucciarelli; Sirous Zeinali; Sepideh Akhavan; Elisabetta Sacchi; P A Merlini; David J Perry
A novel polymorphism in intron 1a of the human factor VII gene (G73A): study of a healthy Italian population and of 190 young survivors of myocardial infarction.
British journal of haematology 2000;108(2):247-53.
2000: Pier M Mannucci
Aspects of the clinical management of hereditary thrombophilia: a personal perspective.
Haemostasis 2000;30 Suppl 2():11-5.
2000: Angelo V Marzano; A B Federici; G Gasparini; Pier M Mannucci; Ruggero Caputo; Emilio Berti
Coagulation factor XIII, endothelial damage and systemic sclerosis.
European journal of dermatology : EJD 2000;10(1):14-7.
2000: Giancarlo Castaman; J C J Eikenboom; A Lattuada; Pier M Mannucci; Francesco Rodeghiero
Heightened proteolysis of the von Willebrand factor subunit in patients with von Willebrand disease hemizygous or homozygous for the C2362F mutation.
British journal of haematology 2000;108(1):188-90.
1999: J Hermida; Elena M Faioni; Pier M Mannucci
Poor relationship between phenotypes of protein S deficiency and mutations in the protein S alpha gene.
Thrombosis and haemostasis 1999;82(6):1634-8.
1999: Veena Chantarangkul; Armando Tripodi; Bruno Mario Cesana; Pier M Mannucci
Calibration of local systems with lyophilized calibrant plasmas improves the interlaboratory variability of the INR in the Italian external quality assessment scheme.
Thrombosis and haemostasis 1999;82(6):1621-6.
1999: Pier M Mannucci
Thrombotic thrombocytopenic purpura: a simpler diagnosis at last?
Thrombosis and haemostasis 1999;82(5):1380-1.
1999: Elena M Faioni; Franca Franchi; Paolo Bucciarelli; Maurizio Margaglione; Valerio De Stefano; Giancarlo Castaman; G Finazzi; Pier M Mannucci
Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (factor V Leiden).
Blood 1999;94(9):3062-6.
1999: Pier M Mannucci; E G Tuddenbam
The hemophilias: progress and problems.
Seminars in hematology 1999;36(4 Suppl 7):104-17.
1999: Ida Martinelli; Marco Cattaneo; Emanuela Taioli; Valerio De Stefano; P Chiusolo; Pier M Mannucci
Genetic risk factors for superficial vein thrombosis.
Thrombosis and haemostasis 1999;82(4):1215-7.
1999: Flora Peyvandi; Pier M Mannucci
Rare coagulation disorders.
Thrombosis and haemostasis 1999;82(4):1207-14.
1999: Manijeh Lak; M Keihani; F Elahi; Flora Peyvandi; Pier M Mannucci
Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia.
British journal of haematology 1999;107(1):204-6.
1999: Robert A S Ariëns; Marco Moia; E Rivolta; C Ponticelli; Pier M Mannucci
High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
Thrombosis and haemostasis 1999;82(3):1020-3.
1999: Marzia Menegatti; G Cristalli; L Gallo; Pier M Mannucci; FI Pareti
Effect of adenosine derivatives on in vitro thrombus formation induced by shear stress.
Haematologica 1999;84(8):721-5.
1999: V Di Carlo; G Agnelli; P Prandoni; S Coccheri; G F Gensini; Francesco Gianese; Pier M Mannucci
Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group.
Thrombosis and haemostasis 1999;82(1):30-4.
1999: Diego Ardissino; Pier M Mannucci; Piera Angelica Merlini; F Duca; Raffaela Fetiveau; Luca Tagliabue; Marco Tubaro; Marcello Galvani; Filippo Ottani; Maurizio Ferrario; J Corral; M Margaglione
Prothrombotic genetic risk factors in young survivors of myocardial infarction.
Blood 1999;94(1):46-51.
1999: Marco Cattaneo; Pier M Mannucci
Current status of non-transfusional haemostatic agents.
Haematologica 1999;84 Suppl EHA-4():120-3.
1999: Sepideh Akhavan; E Rocha; Sirous Zeinali; Pier M Mannucci
Gly319 --> arg substitution in the dysfunctional prothrombin Segovia.
British journal of haematology 1999;105(3):667-9.
1999: Augusto B Federici; Pier M Mannucci
Diagnosis and management of von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 1999;5 Suppl 2():28-37.
1999: Paolo Bucciarelli; Frits R Rosendaal; Armando Tripodi; Pier M Mannucci; Valerio De Stefano; G Palareti; G Finazzi; Francesco Baudo; R Quintavalla
Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(4):1026-33.
1999: Ida Martinelli; Emanuela Taioli; Paolo Bucciarelli; Sepideh Akhavan; Pier M Mannucci
Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis.
Arteriosclerosis, thrombosis, and vascular biology 1999;19(3):700-3.
1999: Robert A S Ariëns; G Alberio; Marco Moia; Pier M Mannucci
Low levels of heparin-releasable tissue factor pathway inhibitor in young patients with thrombosis.
Thrombosis and haemostasis 1999;81(2):203-7.
1999: Elena Santagostino; Alessandro Gringeri; Pier M Mannucci
Home treatment with recombinant activated factor VII in patients with factor VIII inhibitors: the advantages of early intervention.
British journal of haematology 1999;104(1):22-6.
1998: Manijeh Lak; Ramazan Ali Sharifian; Flora Peyvandi; Pier M Mannucci
Symptoms of inherited factor V deficiency in 35 Iranian patients.
British journal of haematology 1998;103(4):1067-9.
1998: Augusto B Federici; F Stabile; Giancarlo Castaman; Maria Teresa Canciani; Pier M Mannucci
Treatment of acquired von Willebrand syndrome in patients with monoclonal gammopathy of uncertain significance: comparison of three different therapeutic approaches.
Blood 1998;92(8):2707-11.
1998: Eugenia Biguzzi; E Mozzi; A Alatri; Emanuela Taioli; Marco Moia; Pier M Mannucci
The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors.
Thrombosis and haemostasis 1998;80(4):575-7.
1998: Elena M Faioni; Franca Franchi; Daniela Asti; Pier M Mannucci
Activation of the protein C pathway in hereditary thrombophilia.
Thrombosis and haemostasis 1998;80(4):557-60.
1998: Marco Cattaneo; Maurizio Vecchi; Maddalena L Zighetti; Simone Saibeni; Ida Martinelli; Paolo Omodei; Pier M Mannucci; Roberto de Franchis
High prevalence of hyperchomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications?
Thrombosis and haemostasis 1998;80(4):542-5.
1998: Ida Martinelli; Pier M Mannucci; Valerio De Stefano; Emanuela Taioli; Vincenzo Rossi; Francesca Crosti; Katia Paciaroni; G Leone; Elena M Faioni
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families.
Blood 1998;92(7):2353-8.
1998: Armando Tripodi; Sepideh Akhavan; Daniela Asti; Elena M Faioni; Pier M Mannucci
Laboratory screening of thrombophilia. Evaluation of the diagnostic efficacy of a global test to detect congenital deficiencies of the protein C anticoagulant pathway.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1998;9(6):485-9.
1998: Elena Santagostino; Alessandro Gringeri; Myrvet Muça-Perja; Pier M Mannucci
A prospective clinical trial of implantable central venous access in children with haemophilia.
British journal of haematology 1998;102(5):1224-8.
1998: Marco Cattaneo; Franca Franchi; Maddalena L Zighetti; Ida Martinelli; Daniela Asti; Pier M Mannucci
Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: relationships with plasma homocysteine levels.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(9):1371-5.
1998: Pier M Mannucci
von Willebrand factor: a marker of endothelial damage?
Arteriosclerosis, thrombosis, and vascular biology 1998;18(9):1359-62.
1998: A Alatri; P Bucciarelli; Marco Moia; Pier M Mannucci
Occult cancer and venous thromboembolism.
Thrombosis and haemostasis 1998;80(2):347-8.
1998: Veena Chantarangkul; Armando Tripodi; Marigrazia Clerici; B Negri; Pier M Mannucci
Assessment of the influence of citrate concentration on the International Normalized Ratio (INR) determined with twelve reagent-instrument combinations.
Thrombosis and haemostasis 1998;80(2):258-62.
1998: Pier M Mannucci
Hemostatic drugs.
The New England journal of medicine 1998;339(4):245-53.
1998: Elena Santagostino; Massimo Colombo; D Cultraro; Myrvet Muça-Perja; Alessandro Gringeri; Pier M Mannucci
High prevalence of serum cryoglobulins in multitransfused hemophilic patients with chronic hepatitis C.
Blood 1998;92(2):516-9.
1998: Pier M Mannucci
Treatment of von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(4):661-4.
1998: Pier M Mannucci
Haemophilia treatment protocols around the world: towards a consensus.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4(4):421.
1998: Flora Peyvandi; Pier M Mannucci; Manijeh Lak; M Abdoullahi; Sirous Zeinali; Ramazan Ali Sharifian; D Perry
Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients.
British journal of haematology 1998;102(2):626-8.
1998: Ida Martinelli; Elisabetta Sacchi; G Landi; Emanuela Taioli; F Duca; Pier M Mannucci
High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
The New England journal of medicine 1998;338(25):1793-7.
1998: Alessandro Gringeri; Elena Santagostino; Myrvet Muça-Perja; Pier M Mannucci; Jean-François Zagury; Bernard Bizzini; Abderrahim LACHGAR; M Carcagno; Jay Rappaport; M Criscuolo; William A Blattner; Arsène Burny; Robert C Gallo; Daniel Zagury
Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients.
Journal of human virology 1998;1(4):293-8.
1998: F De Filippi; Roberto Castelli; Marco Cicardi; Roberta Soffredini; Maria Grazia Rumi; E Silini; Pier M Mannucci; Massimo Colombo
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor.
Transfusion 1998;38(3):307-11.
1998: Flora Peyvandi; Edward G D Tuddenham; A M Akhtari; Manijeh Lak; Pier M Mannucci
Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and factor VIII.
British journal of haematology 1998;100(4):773-6.
1998: Armando Tripodi; Marco Cattaneo; A Molteni; Bruno Mario Cesana; Pier M Mannucci
Changes of prothrombin fragment 1+2 (F 1+2) as a function of increasing intensity of oral anticoagulation--considerations on the suitability of F 1+2 to monitor oral anticoagulant treatment.
Thrombosis and haemostasis 1998;79(3):571-3.
1998: Armando Tripodi; Veena Chantarangkul; B Negri; Pier M Mannucci
Standardization of the APC resistance test. Effects of normalization of results by means of pooled normal plasma.
Thrombosis and haemostasis 1998;79(3):564-6.
1998: F Tradati; Massimo Colombo; Pier M Mannucci; Maria Grazia Rumi; Cristina De Fazio; G Gamba; Nicola Ciavarella; Angiola Rocino; Massimo Morfini; A Scaraggi; Emanuela Taioli
A prospective multicenter study of hepatocellular carcinoma in italian hemophiliacs with chronic hepatitis C. The Study Group of the Association of Italian Hemophilia Centers.
Blood 1998;91(4):1173-7.
1998: Armando Tripodi; Veena Chantarangkul; B Negri; Marigrazia Clerici; Pier M Mannucci
International collaborative study for the calibration of a proposed reference preparation for thromboplastin, human recombinant, plain. On behalf of the Subcommittee on Control of Anticoagulation.
Thrombosis and haemostasis 1998;79(2):439-43.
1998: Augusto B Federici; Pier M Mannucci
Optimizing therapy with factor VIII/von Willebrand factor concentrates in von Willebrand disease.
Haemophilia : the official journal of the World Federation of Hemophilia 1998;4 Suppl 3():7-10.
1998: Pier M Mannucci
Treatment of von Willebrand disease.
International journal of clinical & laboratory research 1998;28(4):211-4.
1997: F De Filippi; Massimo Colombo; Maria Grazia Rumi; F Tradati; Daniele Prati; Alberto Zanella; Pier M Mannucci
High rates of hepatitis G virus infection in multitransfused patients with hemophilia.
Blood 1997;90(11):4634-7.
1997: Elena M Faioni; Carla Valsecchi; A Palla; Emanuela Taioli; Cristina Razzari; Pier M Mannucci
Free protein S deficiency is a risk factor for venous thrombosis.
Thrombosis and haemostasis 1997;78(5):1343-6.
1997: Pier M Mannucci
Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years.
Blood 1997;90(7):2515-21.
1997: Marco Cattaneo; M Y Tsai; Paolo Bucciarelli; Emanuela Taioli; Maddalena L Zighetti; M Bignell; Pier M Mannucci
A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506).
Arteriosclerosis, thrombosis, and vascular biology 1997;17(9):1662-6.
1997: Augusto B Federici; Pier M Mannucci; F Stabile; Maria Teresa Canciani; N Di Rocco; S Miyata; Jerry Ware; Zaverio M Ruggeri
A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype.
Thrombosis and haemostasis 1997;78(3):1132-7.
1997: R Zanettini; Donato Bettega; O Agostoni; B Ballestra; G del Rosso; R di Michele; Pier M Mannucci
Exercise training in mild hypertension: effects on blood pressure, left ventricular mass and coagulation factor VII and fibrinogen.
Cardiology 1997;88(5):468-73.
1997: Elisabetta Sacchi; Luca Tagliabue; F Duca; Pier M Mannucci
High frequency of the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in Northern Italy.
Thrombosis and haemostasis 1997;78(2):963-4.
1997: Armando Tripodi; Veena Chantarangkul; Marigrazia Clerici; B Negri; Pier M Mannucci
Determination of the International Sensitivity Index of a new near-patient testing device to monitor oral anticoagulant therapy--overview of the assessment of conformity to the calibration model.
Thrombosis and haemostasis 1997;78(2):855-8.
1997: A Lattuada; Pier M Mannucci; C Chen; Cristina Legnani; G Palareti
Transfusion requirements are correlated with the degree of proteolysis of von Willebrand factor during orthotopic liver transplantation.
Thrombosis and haemostasis 1997;78(2):813-9.
1997: Elena M Faioni; Cristina Razzari; Ida Martinelli; D Panzeri; Franca Franchi; Pier M Mannucci
Resistance to activated protein C in unselected patients with arterial and venous thrombosis.
American journal of hematology 1997;55(2):59-64.
1997: M G Rumi; Elena Santagostino; Massimo Morfini; Alessandro Gringeri; Giuseppe Tagariello; A Chistolini; Patrizia Pontisso; A Tagger; Massimo Colombo; Pier M Mannucci
A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers.
Blood 1997;89(10):3529-33.
1997: Marco Cattaneo; Rossana Lombardi; Maddalena L Zighetti; Christian Gachet; P Ohlmann; J P Cazenave; Pier M Mannucci
Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
Thrombosis and haemostasis 1997;77(5):986-90.
1997: Elena Santagostino; Pier M Mannucci; Alessandro Gringeri; Alberta Azzi; Massimo Morfini; Roberto Musso; R Santoro; Mario Schiavoni
Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization.
Transfusion 1997;37(5):517-22.
1997: Ida Martinelli; Marco Cattaneo; D Panzeri; Emanuela Taioli; Pier M Mannucci
Risk factors for deep venous thrombosis of the upper extremities.
Annals of internal medicine 1997;126(9):707-11.
1997: Massimo Cugno; Marco Cicardi; Bianca Bottasso; Raffaella Coppola; R Paonessa; Pier M Mannucci; Angelo Agostoni
Activation of the coagulation cascade in C1-inhibitor deficiencies.
Blood 1997;89(9):3213-8.
1997: Pier M Mannucci; Daniela Mari; Giuliana Merati; Flora Peyvandi; Luca Tagliabue; Elisabetta Sacchi; Emanuela Taioli; Paolo Sansoni; S Bertolini; C Franceschi
Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(4):755-9.
1997: Diego Ardissino; Piera Angelica Merlini; R Ariëns; R Coppola; Ezio Bramucci; Pier M Mannucci
Tissue-factor antigen and activity in human coronary atherosclerotic plaques.
Lancet 1997;349(9054):769-71.
1997: Ida Martinelli; Marco Cattaneo; D Panzeri; Pier M Mannucci
Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism.
Thrombosis and haemostasis 1997;77(3):440-3.
1997: Armando Tripodi; B Negri; R M Bertina; Pier M Mannucci
Screening for the FV:Q506 mutation--evaluation of thirteen plasma-based methods for their diagnostic efficacy in comparison with DNA analysis.
Thrombosis and haemostasis 1997;77(3):436-9.
1997: Maddalena L Zighetti; Marco Cattaneo; C R Falcon; Rossana Lombardi; S Harari; S Savoritto; Pier M Mannucci
Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension.
Thrombosis research 1997;85(3):279-82.
1997: Pier M Mannucci
Markers of hypercoagulability in cancer patients.
Haemostasis 1997;27 Suppl 1():25-31.
1997: Pier M Mannucci
Treatment of von Willebrand's disease.
Journal of internal medicine. Supplement 1997;740():129-32.
1996: Pier M Mannucci; Donato Bettega; Veena Chantarangkul; Armando Tripodi; Virgilio Sacchini; U Veronesi
Effect of tamoxifen on measurements of hemostasis in healthy women.
Archives of internal medicine 1996;156(16):1806-10.
1996: F I Pareti; Marco Cattaneo; L Carpinelli; Maddalena L Zighetti; C Bressi; Pier M Mannucci; Z M Ruggeri
Evaluation of the abnormal platelet function in von Willebrand disease by the blood filtration test.
Thrombosis and haemostasis 1996;76(3):460-8.
1996: Alessandro Gringeri; Elena Santagostino; M Cusini; Myrvet Muça-Perja; A Marinoni; Pier M Mannucci; Arsène Burny; M Criscuolo; W Lu; J M Andrieru; J P Mbika; Abderrahim LACHGAR; L S Fall; VIDA CHAMS; M Feldman; P Hermans; Jean-François Zagury; Bernard Bizzini; M Musicco; Daniel Zagury
Absence of clinical, virological, and immunological signs of progression in HIV-1-infected patients receiving active anti-interferon-alpha immunization: a 30-month follow-up report.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13(1):55-67.
1996: G Landi; E Cella; Ida Martinelli; Luca Tagliabue; Pier M Mannucci; D Zerbi
Arg506Gln factor V mutation and cerebral ischemia in the young.
Stroke; a journal of cerebral circulation 1996;27(9):1697-8.
1996: Raffaella Coppola; P Cristilli; M Cugno; Robert A S Ariëns; Daniela Mari; Pier M Mannucci
Measurement of activated factor XII in health and disease.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(5):530-5.
1996: Pier M Mannucci
The choice of plasma-derived clotting factor concentrates.
Baillière's clinical haematology 1996;9(2):273-90.
1996: Domenico Ferro; C Quintarelli; A Lattuada; R Leo; M Alessandroni; Pier M Mannucci; Francesco Violi
High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia.
Hepatology (Baltimore, Md.) 1996;23(6):1377-83.
1996: Ida Martinelli; Bianca Bottasso; F Duca; Elena M Faioni; Pier M Mannucci
Heightened thrombin generation in individuals with resistance to activated protein C.
Thrombosis and haemostasis 1996;75(5):703-5.
1996: Armando Tripodi; Pier M Mannucci
Markers of activated coagulation and their usefulness in the clinical laboratory.
Clinical chemistry 1996;42(5):664-9.
1996: Valerio De Stefano; G Finazzi; Pier M Mannucci
Inherited thrombophilia: pathogenesis, clinical syndromes, and management.
Blood 1996;87(9):3531-44.
1996: Daniela Mari; Pier M Mannucci; F Duca; S Bertolini; C Franceschi
Mutant factor V (Arg506Gln) in healthy centenarians.
Lancet 1996;347(9007):1044.
1996: Pier M Mannucci; F Duca; Flora Peyvandi; Luca Tagliabue; Giuliana Merati; Ida Martinelli; Marco Cattaneo
Frequency of factor V Arg506 Gln in Italians.
Thrombosis and haemostasis 1996;75(4):694.
1996: Elena M Faioni; Franca Franchi; Daniela Asti; Pier M Mannucci
Resistance to activated protein C mimicking dysfunctional protein C: diagnostic approach.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(3):349-52.
1996: Elisabetta Sacchi; Luca Tagliabue; R Scoglio; C Baroncini; Raffaella Coppola; francesco bernardi; Pier M Mannucci
Plasma factor VII levels are influenced by a polymorphism in the promoter region of the FVII gene.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1996;7(2):114-7.
1996: Ida Martinelli; G Landi; Giuliana Merati; R Cella; Alberto Tosetto; Pier M Mannucci
Factor V gene mutation is a risk factor for cerebral venous thrombosis.
Thrombosis and haemostasis 1996;75(3):393-4.
1996: Augusto B Federici; A Falanga; A Lattuada; N Di Rocco; T Barbui; Pier M Mannucci
Proteolysis of von Willebrand factor is decreased in acute promyelocytic leukaemia by treatment with all-trans-retinoic acid.
British journal of haematology 1996;92(3):733-9.
1996: Bianca Bottasso; Daniela Mari; Raffaella Coppola; N Santoro; M Vaglini; Pier M Mannucci
Hypercoagulability and hyperfibrinolysis in patients with melanoma.
Thrombosis research 1996;81(3):345-52.
1996: Armando Tripodi; Veena Chantarangkul; C Manotti; M Poggi; M Braga; B Akkawat; Paolo Bucciarelli; Pier M Mannucci
A simplified procedure for thromboplastin calibration--the usefulness of lyophilized plasmas assessed in a collaborative study.
Thrombosis and haemostasis 1996;75(2):309-12.
1996: Luigi Bergamaschini; T Santangelo; A Faricciotti; N Ciavarella; Pier M Mannucci; Angelo Agostoni
Study of complement-mediated anaphylaxis in humans. The role of IgG subclasses (IgG1 and/or IgG4) in the complement-activating capacity of immune complexes.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(3):1256-61.
1996: C R Hay; J N Lozier; C A Lee; M Laffan; F Tradati; Elena Santagostino; N Ciavarella; M Schiavoni; H Fukui; A Yoshioka; J Teitel; Pier M Mannucci; C K Kasper
Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey.
Thrombosis and haemostasis 1996;75(1):25-9.
1995: Armando Tripodi; L Poller; A M van den Besselaar; Pier M Mannucci
A proposed scheme for calibration of international reference preparations of thromboplastin for the prothrombin time. On behalf of the Subcommittee on Control of Anticoagulation.
Thrombosis and haemostasis 1995;74(5):1368-9.
1995: AA Arbini; Pier M Mannucci; Kenneth A Bauer
Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis.
Thrombosis and haemostasis 1995;74(5):1255-8.
1995: S Eichinger; Pier M Mannucci; F Tradati; AA Arbini; R D Rosenberg; Kenneth A Bauer
Determinants of plasma factor VIIa levels in humans.
Blood 1995;86(8):3021-5.
1995: Marco Cattaneo; A S Harris; U Strömberg; Pier M Mannucci
The effect of desmopressin on reducing blood loss in cardiac surgery--a meta-analysis of double-blind, placebo-controlled trials.
Thrombosis and haemostasis 1995;74(4):1064-70.
1995: Elena Santagostino; Alessandro Gringeri; Luigina Tagliavacca; Pier M Mannucci
Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
Thrombosis and haemostasis 1995;74(2):619-21.
1995: Robert A S Ariëns; Raffaella Coppola; I Potenza; Pier M Mannucci
The increase with age of the components of the tissue factor coagulation pathway is gender-dependent.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1995;6(5):433-7.
1995: Pier M Mannucci
Effects of factor VIII concentrates on the immune system of patients with hemophilia.
Thrombosis and haemostasis 1995;74(1):437-9.
1995: Daniela Mari; Pier M Mannucci; Raffaella Coppola; Bianca Bottasso; Kenneth A Bauer; R D Rosenberg
Hypercoagulability in centenarians: the paradox of successful aging.
Blood 1995;85(11):3144-9.
1995: Armando Tripodi; Veena Chantarangkul; B Akkawat; Marigrazia Clerici; Pier M Mannucci
A partial factor V deficiency in anticoagulated lyophilized plasmas has been identified as a cause of the international normalized ratio discrepancy in the external quality assessment scheme.
Thrombosis research 1995;78(4):283-92.
1995: Alessandro Gringeri; Elena Santagostino; Pier M Mannucci; L Siracusano; A Marinoni; M Criscuolo; M Carcagno; L S Fall; J P M'Bika; Bernard Bizzini
Anti-alpha interferon immunization: safety and immunogenicity in asymptomatic HIV positive patients at high risk of disease progression.
Cellular and molecular biology (Noisy-le-Grand, France) 1995;41(3):381-7.
1995: Elena Santagostino; Alessandro Gringeri; D Cultraro; F Tradati; L Siracusano; A Marinoni; Pier M Mannucci
Factors associated with progression to AIDS and mortality in a cohort of HIV-infected patients with hemophilia followed up since seroconversion.
Cellular and molecular biology (Noisy-le-Grand, France) 1995;41(3):371-80.
1995: Elisabetta Sacchi; M Pinotti; Giovanna Marchetti; Giuliana Merati; Luca Tagliabue; Pier M Mannucci; francesco bernardi
Protein S mRNA in patients with protein S deficiency.
Thrombosis and haemostasis 1995;73(5):746-9.
1995: Marco Cattaneo; F I Pareti; Maddalena L Zighetti; Anna Lecchi; Rossana Lombardi; Pier M Mannucci
Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
The Journal of laboratory and clinical medicine 1995;125(4):540-7.
1995: Pier M Mannucci
Platelet von Willebrand factor in inherited and acquired bleeding disorders.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(7):2428-32.
1995: Luigi Bergamaschini; Pier M Mannucci; Augusto B Federici; R Coppola; S Guzzoni; Angelo Agostoni
Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
The Journal of laboratory and clinical medicine 1995;125(3):348-55.
1995: Marco Cicardi; Pier M Mannucci; Roberto Castelli; Maria Grazia Rumi; Angelo Agostoni
Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate.
Transfusion 1995;35(3):209-12.
1995: Pier M Mannucci; Augusto B Federici
Antibodies to von Willebrand factor in von Willebrand disease.
Advances in experimental medicine and biology 1995;386():87-92.
1995: Augusto B Federici; Pier M Mannucci; F Stabile; G Rossi; G Piseddu
Orthotopic liver transplantation in a patient with severe hemophilia A: a life-saving treatment for the first Italian case.
International journal of clinical & laboratory research 1995;25(1):44-6.
1995: R Coppola; S Tombesi; P Cristilli; L Bergamaschini; Pier M Mannucci
Comparison of two immunoassays for the complement protein C4b-binding protein in health and disease.
International journal of clinical & laboratory research 1995;25(2):88-92.
1994: Marco Cattaneo; Maddalena L Zighetti; Rossana Lombardi; Pier M Mannucci
Role of ADP in platelet aggregation at high shear: studies in a patient with congenital defect of platelet responses to ADP.
British journal of haematology 1994;88(4):826-9.
1994: Ida Martinelli; Marco Moia; D Panzeri; L Tondo; Pier M Mannucci
Prognostic value of the activated partial thromboplastin time after orthotopic liver transplantation: a prospective study.
Journal of hepatology 1994;21(5):917.
1994: Elena Santagostino; Alessandro Gringeri; Angiola Rocino; A Zanetti; R de Biasi; Pier M Mannucci
Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients.
Thrombosis and haemostasis 1994;72(4):508-10.
1994: Veena Chantarangkul; Armando Tripodi; Pier M Mannucci
Results of a collaborative study for fibrinogen measurement. Evidence that the use of a common calibrator improves interlaboratory agreement.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1994;5(5):761-6.
1994: Pier M Mannucci
Mechanisms, markers and management of coagulation activation.
British medical bulletin 1994;50(4):851-70.
1994: Alessandro Gringeri; Elena Santagostino; Pier M Mannucci; F Tradati; D Cultraro; A Buzzi; M Criscuolo; A David; L Guillemot; Françoise Barré-Sinoussi
A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-IFN alpha immunization.
Journal of acquired immune deficiency syndromes 1994;7(9):978-88.
1994: Pier M Mannucci
Biochemical characteristics of therapeutic plasma concentrates used in the treatment of von Willebrand disease.
Haemostasis 1994;24(5):285-8.
1994: Marco Moia; Pier M Mannucci; M Pini; P Prandoni; V Gurewich
A pilot study of pro-urokinase in the treatment of deep vein thrombosis.
Thrombosis and haemostasis 1994;72(3):430-3.
1994: Pier M Mannucci; Kenneth A Bauer; Elena Santagostino; Elena M Faioni; S Barzegar; Raffaella Coppola; R D Rosenberg
Activation of the coagulation cascade after infusion of a factor XI concentrate in congenitally deficient patients.
Blood 1994;84(4):1314-9.
1994: Armando Tripodi; Veena Chantarangkul; M Braga; L Poller; J W ten Cate; A M van den Besselaar; Pier M Mannucci
Results of a multicenter study assessing the status of standardization of a recombinant thromboplastin for the control of oral anticoagulant therapy.
Thrombosis and haemostasis 1994;72(2):261-7.
1994: C R Falcon; Marco Cattaneo; D Panzeri; Ida Martinelli; Pier M Mannucci
High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1994;14(7):1080-3.
1994: Elena Santagostino; Pier M Mannucci; Alessandro Gringeri; Giuseppe Tagariello; F Baudo; Kenneth A Bauer; R D Rosenberg
Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.
Thrombosis and haemostasis 1994;71(6):737-40.
1994: Armando Tripodi; Veena Chantarangkul; Bianca Bottasso; Pier M Mannucci
Poor comparability of prothrombin fragment 1 + 2 values measured by two commercial ELISA methods: influence of different anticoagulants and standards.
Thrombosis and haemostasis 1994;71(5):605-8.
1994: Pier M Mannucci; D B Brettler; L M Aledort; Jeanne M Lusher; C F Abildgaard; R S Schwartz; D Hurst
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group.
Blood 1994;83(7):1958-62.
1994: Pier M Mannucci; A Gringeri; Elena Santagostino; Luisa Romano'; A Zanetti
Low risk of transmission of hepatitis E virus by large-pool coagulation factor concentrates.
Lancet 1994;343(8897):597-8.
1994: Marco Cattaneo; L Simoni; Alessandro Gringeri; Pier M Mannucci
Patients with severe von Willebrand disease are insensitive to the releasing effect of DDAVP: evidence that the DDAVP-induced increase in plasma factor VIII is not secondary to the increase in plasma von Willebrand factor.
British journal of haematology 1994;86(2):333-7.
1994: Marco Cattaneo; B Akkawat; R L Kinlough-Rathbone; M A Packham; C Cimminiello; Pier M Mannucci
Ticlopidine facilitates the deaggregation of human platelets aggregated by thrombin.
Thrombosis and haemostasis 1994;71(1):91-4.
1994: Pier M Mannucci; Elena Santagostino; E Di Bona; G Gentili; A Ghirardini; M Schiavoni; A Mele
The outbreak of hepatitis A in Italian patients with hemophilia: facts and fancies.
Vox sanguinis 1994;67 Suppl 1():31-5.
1994: Pier M Mannucci
Impact of recombinant factor VIII on hemophilia care.
Vox sanguinis 1994;67 Suppl 3():49-52.
1994: F Tradati; Alessandro Gringeri; Elena Santagostino; D Cultraro; L Simoni; Cristina De Fazio; Gianni Mezzi; M Cappelletti; Alberto Malesci; Pier M Mannucci
Prevalence of pancreatic disorders in HIV-infected hemophiliacs: diagnostic methods and their clinical significance.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 1994;48(2):89-93.
1994: Pier M Mannucci; Alessandro Gringeri; G Savidge; P Gatenby; Y Laurian; I Pabinger-Fasching; J M Martinez-Vazquez; E W Hessey; H M Steel
Randomized double-blind, placebo-controlled trial of twice-daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1. European-Australian Haemophilia Collaborative Study Group.
British journal of haematology 1994;86(1):174-9.
1994: Ida Martinelli; Marco Moia; Bruno Gridelli; D Panzeri; M Langer; Pier M Mannucci
Prognostic value of the activated partial thromboplastin time after orthotopic liver transplantation. A prospective study.
International journal of clinical & laboratory research 1994;24(4):220-2.
1994: Robert Purcell; Pier M Mannucci; S Gdovin; Alessandro Gringeri; Massimo Colombo; A Mele; N Schinaia; N Ciavarella; S U Emerson
Virology of the hepatitis A epidemic in Italy.
Vox sanguinis 1994;67 Suppl 4():2-7; discussion 24-6.
1994: Massimo Morfini; Pier M Mannucci; N Ciavarella; M Schiavoni; Alessandro Gringeri; D Rafanelli; E Di Bona; A Chistolini; A Tagliaferri; G Rodorigo
Prevalence of infection with the hepatitis C virus among Italian hemophiliacs before and after the introduction of virally inactivated clotting factor concentrates: a retrospective evaluation.
Vox sanguinis 1994;67(2):178-82.
1994: Pier M Mannucci; S Gdovin; Alessandro Gringeri; Massimo Colombo; A Mele; N Schinaia; N Ciavarella; S U Emerson; Robert Purcell
Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.
Annals of internal medicine 1994;120(1):1-7.
1993: Armando Tripodi; A A Arbini; Veena Chantarangkul; Donato Bettega; Pier M Mannucci
Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio?
Thrombosis and haemostasis 1993;70(6):921-4.
1993: Elena M Faioni; Franca Franchi; Daniela Asti; Elisabetta Sacchi; francesco bernardi; Pier M Mannucci
Resistance to activated protein C in nine thrombophilic families: interference in a protein S functional assay.
Thrombosis and haemostasis 1993;70(6):1067-71.
1993: Augusto B Federici; Pier M Mannucci; E Fogato; P Ghidoni; L Matturri
Autopsy findings in three patients with von Willebrand disease type IIB and type III: presence of atherosclerotic lesions without occlusive arterial thrombi.
Thrombosis and haemostasis 1993;70(5):758-61.
1993: Roberto de Franchis; P G Arcidiacono; L Carpinelli; Bruno Andreoni; L Cestari; S Brunati; A Zambelli; G Battaglia; Pier M Mannucci
Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. New Italian Endoscopic Club.
Hepatology (Baltimore, Md.) 1993;18(5):1102-7.
1993: Elena Santagostino; Pier M Mannucci; Alessandro Gringeri; Maria Grazia Rumi; D Rafanelli; Angiola Rocino; M Schiavoni; A Chistolini; E Di Bona; G Muleo
Accelerated schedule of hepatitis B vaccination in patients with hemophilia.
Journal of medical virology 1993;41(2):95-8.
1993: Guglielmo Mariani; T Di Paolantonio; R Baklaya; Massimo Morfini; Pier M Mannucci
Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia.
Transfusion 1993;33(10):814-8.
1993: C R Falcon; Marco Cattaneo; A Ghidoni; Pier M Mannucci
The in vitro production of thromboxane B2 by platelets of diabetic patients is normal at physiological concentrations of ionized calcium.
Thrombosis and haemostasis 1993;70(3):389-92.
1993: Armando Tripodi; Veena Chantarangkul; A A Arbini; Marco Moia; Pier M Mannucci
Effects of hirudin on activated partial thromboplastin time determined with ten different reagents.
Thrombosis and haemostasis 1993;70(2):286-8.
1993: Armando Tripodi; Pier M Mannucci; Veena Chantarangkul; Bianca Bottasso; A A Arbini; S Della Bella; Raffaella Scorza
Markers of procoagulant imbalance in patients with localized melanomas and autoimmune disorders.
British journal of haematology 1993;84(4):670-4.
1993: Pier M Mannucci
Modern treatment of hemophilia: from the shadows towards the light.
Thrombosis and haemostasis 1993;70(1):17-23.
1993: Elena M Faioni; A Krachmalnicoff; S I Bearman; Augusto B Federici; Adriano Decarli; ALESSANDRO MASSIMO GIANNI; G B McDonald; Pier M Mannucci
Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver.
Blood 1993;81(12):3458-62.
1993: Marco Cattaneo; Rossana Lombardi; Donato Bettega; Anna Lecchi; Pier M Mannucci
Shear-induced platelet aggregation is potentiated by desmopressin and inhibited by ticlopidine.
Arteriosclerosis and thrombosis : a journal of vascular biology / American Heart Association 1993;13(3):393-7.
1993: A M Randi; Elisabetta Sacchi; Giancarlo Castaman; Francesco Rodeghiero; Pier M Mannucci
The genetic defect of type I von Willebrand disease "Vicenza" is linked to the von Willebrand factor gene.
Thrombosis and haemostasis 1993;69(2):173-6.
1993: Augusto B Federici; Scott Darrell Berkowitz; A Lattuada; Pier M Mannucci
Degradation of von Willebrand factor in patients with acquired clinical conditions in which there is heightened proteolysis.
Blood 1993;81(3):720-5.
1993: Pier M Mannucci
Clinical evaluation of viral safety of coagulation factor VIII and IX concentrates.
Vox sanguinis 1993;64(4):197-203.
1993: Augusto B Federici; P G de Groot; M Moia; M J Ijsseldijk; J J Sixma; Pier M Mannucci
Type I von Willebrand disease, subtype 'platelet low': decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells.
British journal of haematology 1993;83(1):88-93.
1993: Marco Moia; Ida Martinelli; Pier M Mannucci
Laboratory measures of hemostasis for monitoring liver graft function.
Seminars in thrombosis and hemostasis 1993;19(3):238-42.
1993: Pier M Mannucci
Viral safety of coagulation factor concentrates.
Developments in biological standardization 1993;81():253-9.
1993: Ida Martinelli; Marco Moia; A Arbini; Armando Tripodi; Pier M Mannucci
Ischemic stroke in congenital (type II C) defective antithrombin III.
International journal of clinical & laboratory research 1993;23(4):212-4.
1993: Luigina Tagliavacca; Elisabetta Sacchi; Pier M Mannucci
Carrier detection and feasibility of prenatal diagnosis of hemophilia B by multiplex polymerase chain reaction.
International journal of clinical & laboratory research 1993;23(3):169-71.
1992: Marco Cattaneo; Anna Lecchi; A M Randi; J L McGregor; Pier M Mannucci
Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
Blood 1992;80(11):2787-96.
1992: Elisabetta Sacchi; C Stefanile; Luigina Tagliavacca; Pier M Mannucci; A Bianchi Bonomi
Usefulness of determination of factor VIII intron 7 polymorphism by a non-radioactive technique for carrier detection of hemophilia A.
Thrombosis and haemostasis 1992;68(5):622-3.
1992: Raffaella Coppola; S Tombesi; F Valentini; S Alborali; Alberto Albertini; Pier M Mannucci
Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein.
Thrombosis research 1992;68(3):283-93.
1992: Raffaella Coppola; S Tombesi; F Valentini; S Alborali; Alberto Albertini; Pier M Mannucci
Characterization of a Ca (II)-independent monoclonal antibody that lacks reactivity with Gla-domainless human factor VII.
Thrombosis research 1992;68(3):269-81.
1992: Marco Cattaneo; Donato Bettega; Rossana Lombardi; Anna Lecchi; Pier M Mannucci
Sustained correction of the bleeding time in an afibrinogenaemic patient after infusion of fresh frozen plasma.
British journal of haematology 1992;82(2):388-90.
1992: Pier M Mannucci; Donato Bettega; Marco Cattaneo
Patterns of development of tachyphylaxis in patients with haemophilia and von Willebrand disease after repeated doses of desmopressin (DDAVP).
British journal of haematology 1992;82(1):87-93.
1992: F I Pareti; Mario Mazzucato; E Bottini; Pier M Mannucci
Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex.
British journal of haematology 1992;82(1):81-6.
1992: A Lattuada; P Varanukulsak; Giancarlo Castaman; Pier M Mannucci
The response of plasma von Willebrand factor to desmopressin (DDAVP) is related to the platelet levels of von Willebrand factor.
Thrombosis research 1992;67(4):467-71.
1992: Veena Chantarangkul; Armando Tripodi; A Arbini; Pier M Mannucci
Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants.
Thrombosis research 1992;67(4):355-65.
1992: Armando Tripodi; R M Bertina; J Conard; I Pabinger; N Sala; Pier M Mannucci
Multicenter evaluation of three commercial methods for measuring protein S antigen.
Thrombosis and haemostasis 1992;68(2):149-54.
1992: Pier M Mannucci
Recommended protocol for the study of the ex vivo biological effects of virus-inactivated plasma concentrates in patients with von Willebrand disease. The von Willebrand Factor Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis and of the von Willebrand Disease Committee of the World Federation of Hemophilia.
Thrombosis and haemostasis 1992;68(1):84-7.
1992: Pier M Mannucci; P M Tenconi; Giancarlo Castaman; F Rodeghiero
Comparison of four virus-inactivated plasma concentrates for treatment of severe von Willebrand disease: a cross-over randomized trial.
Blood 1992;79(12):3130-7.
1992: Marco Moia; Ida Martinelli; Bruno Gridelli; M Langer; D Galmarini; Pier M Mannucci
Prognostic value of hemostatic parameters after liver transplantation.
Journal of hepatology 1992;15(1-2):125-8.
1992: Kenneth A Bauer; Pier M Mannucci; Alessandro Gringeri; F Tradati; S Barzegar; B L Kass; Hugo ten Cate; A S Kestin; D B Brettler; R D Rosenberg
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.
Blood 1992;79(8):2039-47.
1992: Pier M Mannucci; Alessandro Gringeri; R de Biasi; F Baudo; Massimo Morfini; N Ciavarella
Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.
Thrombosis and haemostasis 1992;67(3):310-3.
1992: Alessandro Gringeri; Marco Cattaneo; Elena Santagostino; Pier M Mannucci
Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura.
British journal of haematology 1992;80(3):337-40.
1992: Pier M Mannucci; Armando Tripodi; Bianca Bottasso; F Baudo; G Finazzi; V De Stefano; G Palareti; C Manotti; Maria Gabriella Mazzucconi; Giancarlo Castaman
Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes.
Thrombosis and haemostasis 1992;67(2):200-2.
1992: T Di Paolantonio; Guglielmo Mariani; A Ghirardini; Alessandro Gringeri; Pier M Mannucci; L Mastrullo; R De Biasi; G Giustarini; Massimo Morfini; M Schiavoni
Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate.
Journal of medical virology 1992;36(2):71-4.
1992: Pier M Mannucci; P L Giangrande
Detection of the prethrombotic state due to procoagulant imbalance.
European journal of haematology 1992;48(2):65-9.
1992: Pier M Mannucci; K Schimpf; T Abe; L M Aledort; K Anderle; D B Brettler; M W Hilgartner; P B Kernoff; M Kunschak; C W McMillan
Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group.
Transfusion 1992;32(2):134-8.
1992: Armando Tripodi; A Arbini; Veena Chantarangkul; Pier M Mannucci
Recombinant tissue factor as substitute for conventional thromboplastin in the prothrombin time test.
Thrombosis and haemostasis 1992;67(1):42-5.
1992: P A d'Alessio; G Castaman; F Rodeghiero; H C de Boer; Augusto B Federici; Pier M Mannucci; Philip G de Groot; Jan J Sixma; Jaap-Jan Zwaginga
In vivo experiments indicate that relatively high platelet deposition in von Willebrand's disease 'Vicenza' is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.
Thrombosis research 1992;65(2):221-8.
1992: Augusto B Federici; Scott Darrell Berkowitz; T S Zimmerman; Pier M Mannucci
Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction.
Blood 1992;79(1):38-44.
1992: Pier M Mannucci; Marco Cattaneo
Desmopressin: a nontransfusional treatment of hemophilia and von Willebrand disease.
Haemostasis 1992;22(5):276-80.
1992: Elisabetta Sacchi; A M Randi; Luigina Tagliavacca; Maurizio Sampietro; P Primignani; Pier M Mannucci
Carrier detection and prenatal diagnosis of hemophilia A: 5-years experience at a hemophilia center.
International journal of clinical & laboratory research 1992;21(4):310-3.
1991: Marco Cattaneo; B Akkawat; Anna Lecchi; C Cimminiello; A M Capitanio; Pier M Mannucci
Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate.
Thrombosis and haemostasis 1991;66(6):694-9.
1991: Pier M Mannucci; Kenneth A Bauer; Alessandro Gringeri; S Barzegar; Elena Santagostino; F Tradati; R D Rosenberg
No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate.
British journal of haematology 1991;79(4):606-11.
1991: Elena M Faioni; Franca Franchi; A Krachmalnicoff; C Valsecchi; G L Viganò; G Remuzzi; Pier M Mannucci
Low levels of the anticoagulant activity of protein C in patients with chronic renal insufficiency: an inhibitor of protein C is present in uremic plasma.
Thrombosis and haemostasis 1991;66(4):420-5.
1991: E Bottini; F I Pareti; D Mari; Pier M Mannucci; M L Muggiasca; M Conti
Prevention of hemoperitoneum during ovulation by oral contraceptives in women with type III von Willebrand disease and afibrinogenemia. Case reports.
Haematologica 1991;76(5):431-3.
1991: M Colombo; Pier M Mannucci; D B Brettler; A Girolami; Eric C-Y Lian; Francesco Rodeghiero; I Scharrer; P S Smith; G C White
Hepatocellular carcinoma in hemophilia.
American journal of hematology 1991;37(4):243-6.
1991: Marco Cattaneo; P M Tenconi; Anna Lecchi; Pier M Mannucci
In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Thrombosis research 1991;62(6):717-24.
1991: Armando Tripodi; Marco Moia; Bianca Bottasso; P M Tenconi; Francesco Gianese; Pier M Mannucci
Effects of subcutaneously administered dermatan sulfate (MF 701) on the coagulation and fibrinolytic parameters of healthy volunteers.
Thrombosis research 1991;62(6):663-72.
1991: Pier M Mannucci; M Cattaneo
[New diagnostic methods for the pre-thrombotic state].
Haematologica 1991;76 Suppl 3():271-5.
1991: N Schinaia; A Ghirardini; Flavia Chiarotti; Alessandro Gringeri; Pier M Mannucci
Progression to AIDS among Italian HIV-seropositive haemophiliacs. Italian Group.
AIDS (London, England) 1991;5(4):385-91.
1991: Elena M Faioni; A Krachmalnicoff; C Valsecchi; G Viganò; Pier M Mannucci
Plasma protein S in chronic renal insufficiency.
Thrombosis research 1991;62(1-2):97-101.
1991: Alessandro Gringeri; Elena Santagostino; F Tradati; P L Giangrande; Pier M Mannucci
Adverse effects of treatment with porcine factor VIII.
Thrombosis and haemostasis 1991;65(3):245-7.
1991: Maria Grazia Rumi; Massimo Colombo; R Romeo; Antonio Boschini; A Zanetti; Alessandro Gringeri; Pier M Mannucci
Suboptimal response to hepatitis B vaccine in drug users.
Archives of internal medicine 1991;151(3):574-8.
1991: M Poggio; Armando Tripodi; G Mariani; Pier M Mannucci
Factor VII clotting assay: influence of different thromboplastins and factor VII-deficient plasmas. CISMEL Study Group.
Thrombosis and haemostasis 1991;65(2):160-4.
1991: A M Capitanio; R Sacco; Pier M Mannucci
Pseudopathologies of hemostasis and dental surgery.
Oral surgery, oral medicine, and oral pathology 1991;71(2):184-6.
1991: Pier M Mannucci; Alessandro Gringeri; Marco Cattaneo
Use of recombinant factor VIII in the management of hemophilia.
Current studies in hematology and blood transfusion 1991;(58):46-51.
1991: Pier M Mannucci; A Gringeri
The use of recombinant factor VIII in the management of hemophilia.
La Ricerca in clinica e in laboratorio 1991;21(1):1-7.
1991: Alessandro Gringeri; Elena Santagostino; Pier M Mannucci
Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.
Haemostasis 1991;21(1):1-4.
1991: Pier M Mannucci; M Cattaneo
Alloantibodies in congenital von Willebrand's disease.
La Ricerca in clinica e in laboratorio 1991;21(1):119-25.
1991: S Tombesi; A D'Angelo; Raffaella Coppola; R Belotti; S Ghielmi; Pier M Mannucci; Alberto Albertini
Evaluation of a new method for protein S detection using monoclonal antibodies.
Current studies in hematology and blood transfusion 1991;(58):205-10.
1991: Maurizio Vecchi; Marco Cattaneo; Roberto de Franchis; Pier M Mannucci
Risk of thromboembolic complications in patients with inflammatory bowel disease. Study of hemostasis measurements.
International journal of clinical & laboratory research 1991;21(2):165-70.
1991: Raffaella Coppola; S Tombesi; R Belotti; S Alborali; M Gobbi; Pier M Mannucci; Alberto Albertini
Preliminary characterization of a panel of monoclonal antibodies to human factor VII.
Current studies in hematology and blood transfusion 1991;(58):187-93.
1991: Maurizio Sampietro; Elisabetta Sacchi; A M Randi; Luigina Tagliavacca; C Stefanile; A Krachmalnicoff; M Travi; Bruno Brambati; Gemino Fiorelli; Pier M Mannucci
Prenatal diagnosis and carrier detection of hemophilia A.
Current studies in hematology and blood transfusion 1991;(58):84-7.
1990: Pier M Mannucci; Kenneth A Bauer; Alessandro Gringeri; S Barzegar; Bianca Bottasso; L Simoni; R D Rosenberg
Thrombin generation is not increased in the blood of hemophilia B patients after the infusion of a purified factor IX concentrate.
Blood 1990;76(12):2540-5.
1990: Marco Cattaneo; P M Tenconi; I Alberca; V V Garcia; Pier M Mannucci
Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis.
Thrombosis and haemostasis 1990;64(3):358-60.
1990: Pier M Mannucci; Alessandro R Zanetti; Massimo Colombo; A Chistolini; R De Biasi; R Musso; Giacomo Tamponi
Antibody to hepatitis C virus after a vapour-heated factor VIII concentrate. The Study Group of the Fondazione dell'Emofilia.
Thrombosis and haemostasis 1990;64(2):232-4.
1990: P d'Alessio; Jaap-Jan Zwaginga; H C de Boer; Augusto B Federici; F Rodeghiero; G Castaman; G Mariani; Pier M Mannucci; Philip G de Groot; Jan J Sixma
Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
Thrombosis and haemostasis 1990;64(2):227-31.
1990: Pier M Mannucci; A Gringeri; M Cattaneo
High-purity factor VIII concentrates produced without using monoclonal antibodies.
La Ricerca in clinica e in laboratorio 1990;20(4):227-37.
1990: Maurizio Sampietro; A M Randi; Elisabetta Sacchi; Luigina Tagliavacca; Gemino Fiorelli; Pier M Mannucci
Molecular analysis of severe von Willebrand disease in Italian patients.
Haematologica 1990;75 Suppl 5():195-206.
1990: Giovanna Fabio; R S Smeraldi; Alessandro Gringeri; M Marchini; Paola Bonara; Pier M Mannucci
Susceptibility to HIV infection and AIDS in Italian haemophiliacs is HLA associated.
British journal of haematology 1990;75(4):531-6.
1990: A Tripodi; B Bottasso; Pier M Mannucci
Elevation of thrombin-antithrombin complexes during thrombolytic therapy in patients with myocardial infarction.
La Ricerca in clinica e in laboratorio 1990;20(3):197-202.
1990: Pier M Mannucci; K Schimpf; D B Brettler; N Ciavarella; Massimo Colombo; F Haschke; K Lechner; Jeanne M Lusher; G Weissbach
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group.
Annals of internal medicine 1990;113(1):27-32.
1990: F I Pareti; Augusto B Federici; Marco Cattaneo; Pier M Mannucci
Spontaneous platelet aggregation during pregnancy in a patient with von Willebrand disease type IIB can be blocked by monoclonal antibodies to both platelet glycoproteins Ib and IIb/IIIa.
British journal of haematology 1990;75(1):86-91.
1990: Maria Grazia Rumi; Massimo Colombo; R Romeo; G Colucci; Alessandro Gringeri; Pier M Mannucci
Serum hepatitis B virus DNA detects cryptic hepatitis B virus infections in multitransfused hemophilic patients.
Blood 1990;75(8):1654-8.
1990: Pier M Mannucci; Massimo Morfini
Determination of pharmacokinetics of replacement factor VIII.
Seminars in hematology 1990;27(2 Suppl 2):8-10.
1990: Marco Cattaneo; Maria Teresa Canciani; Anna Lecchi; R L Kinlough-Rathbone; M A Packham; Pier M Mannucci; J F Mustard
Released adenosine diphosphate stabilizes thrombin-induced human platelet aggregates.
Blood 1990;75(5):1081-6.
1990: Maria Grazia Rumi; Massimo Colombo; Alessandro Gringeri; Pier M Mannucci
High prevalence of antibody to hepatitis C virus in multitransfused hemophiliacs with normal transaminase levels.
Annals of internal medicine 1990;112(5):379-80.
1990: Pier M Mannucci; Massimo Cugno; Bianca Bottasso; Francesco Marongiu; M Maniezzo; M Vaglini; N Cascinelli
Changes in fibrinolysis in patients with localized tumors.
European journal of cancer (Oxford, England : 1990) 1990;26(2):83-7.
1990: Pier M Mannucci
Desmopressin: a nontransfusional hemostatic agent.
Annual review of medicine 1990;41():55-64.
1990: Pier M Mannucci
Hepatitis B vaccination in hemophiliacs.
Progress in clinical and biological research 1990;324():113-21.
1990: A Krachmalnicoff; S Tombesi; C Valsecchi; Alberto Albertini; Pier M Mannucci
A monoclonal antibody to human protein S used as the capture antibody for measuring total protein S by enzyme immunoassay.
Clinical chemistry 1990;36(1):43-6.
1990: Armando Tripodi; Franca Franchi; A Krachmalnicoff; Pier M Mannucci
Asymptomatic homozygous protein C deficiency.
Acta haematologica 1990;83(3):152-5.
1989: Augusto B Federici; Pier M Mannucci; Rossana Lombardi; A Lattuada; M L Colibretti; J A Dent; T S Zimmerman
Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity.
American journal of hematology 1989;32(4):287-93.
1989: H K Ploos van Amstel; P H Reitsma; K Hamulyák; C E de Die-Smulders; Pier M Mannucci; R M Bertina
A mutation in the protein S pseudogene is linked to protein S deficiency in a thrombophilic family.
Thrombosis and haemostasis 1989;62(3):897-901.
1989: Pier M Mannucci; A Lattuada; Giancarlo Castaman; Rossana Lombardi; M L Colibretti; N Ciavarella; Francesco Rodeghiero
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease.
Blood 1989;74(7):2433-6.
1989: Marco Cattaneo; Marco Moia; P Delle Valle; P Castellana; Pier M Mannucci
DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor.
Blood 1989;74(6):1972-5.
1989: Pier M Mannucci
Screening for hemostasis during hemorrhagic emergencies.
La Ricerca in clinica e in laboratorio 1989;19(4):339-43.
1989: Pier M Mannucci; Marco Cattaneo; Maria Teresa Canciani; M Maniezzo; M Vaglini; N Cascinelli
Early presence of activated ('exhausted') platelets in malignant tumors (breast adenocarcinoma and malignant melanoma).
European journal of cancer & clinical oncology 1989;25(10):1413-7.
1989: Pier M Mannucci; C Valsecchi; A Krachmalnicoff; Elena M Faioni; Armando Tripodi
Familial dysfunction of protein S.
Thrombosis and haemostasis 1989;62(2):763-6.
1989: Augusto B Federici; R Bader; S Pagani; M L Colibretti; Luigi De Marco; Pier M Mannucci
Binding of von Willebrand factor to glycoproteins Ib and IIb/IIIa complex: affinity is related to multimeric size.
British journal of haematology 1989;73(1):93-9.
1989: Pier M Mannucci; Rossana Lombardi; A Lattuada; P Ruggenenti; G L Viganò; T Barbui; G Remuzzi
Enhanced proteolysis of plasma von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome.
Blood 1989;74(3):978-83.
1989: Ricardo Castillo; Gines Escolar; Joan Monteagudo; Antonio Ordinas; M Garrido; M Moia; Augusto B Federici; Pier M Mannucci
Role for platelet von Willebrand factor in supporting platelet-vessel wall interactions in von Willebrand disease.
American journal of hematology 1989;31(3):153-8.
1989: A Zanetti; Elisabetta Tanzi; Pier M Mannucci
Dissociated antibody responses to the S and pre-S2 regions of the hepatitis B virus after vaccination in hemophiliacs.
Journal of medical virology 1989;28(3):156-8.
1989: Pier M Mannucci; Massimo Colombo
Revision of the protocol recommended for studies of safety from hepatitis of clotting factor concentrates. International Society for Thrombosis and Hemostasis.
Thrombosis and haemostasis 1989;61(3):532-4.
1989: Pier M Mannucci; Alessandro R Zanetti; Alessandro Gringeri; E Tanzi; Massimo Morfini; A Messori; M C Tirindelli; R de Biasi; N Ciavarella; M Colombo
Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.
Archives of internal medicine 1989;149(6):1333-7.
1989: Pier M Mannucci; Rossana Lombardi; A Lattuada; E Perticucci; R Valsecchi; G Remuzzi
Supranormal von Willebrand factor multimers in scleroderma.
Blood 1989;73(6):1586-91.
1989: Philip G de Groot; Augusto B Federici; H C de Boer; P d'Alessio; Pier M Mannucci; Jan J Sixma
von Willebrand factor synthesized by endothelial cells from a patient with type IIB von Willebrand disease supports platelet adhesion normally but has an increased affinity for platelets.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(10):3793-7.
1989: A M Randi; Elisabetta Sacchi; Maurizio Sampietro; G Papaleo; G Muleo; Pier M Mannucci
Diagnosis of hemophilia A in a female subject by using restriction fragment length polymorphisms linked to the factor VIII gene.
La Ricerca in clinica e in laboratorio 1989;19(1):75-9.
1989: A Tripodi; Pier M Mannucci
A survey of inherited thrombotic syndromes in Italy. ad hoc Study Group.
La Ricerca in clinica e in laboratorio 1989;19(1):67-74.
1989: Maria Grazia Rumi; R Romeo; M Bortolini; Alessandro Gringeri; Alessandro R Zanetti; Pier M Mannucci; Massimo Colombo
Immunogenicity of a yeast-recombinant hepatitis B vaccine in high-risk children.
Journal of medical virology 1989;27(1):48-51.
1989: Armando Tripodi; M Poggio; L Scapellato; Pier M Mannucci
Automated amidolytic method for evaluating the activated partial thromboplastin time compared with a conventional coagulation method.
Haemostasis 1989;19(4):205-12.
1988: Pier M Mannucci; Alessandro Gringeri; Massimo Morfini; R De Biasi; M C Tirindelli; Giacomo Tamponi; F Baudo; V Carnelli; N Ciavarella; M Colombo
Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs.
American journal of hematology 1988;29(4):211-4.
1988: Pier M Mannucci
Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders.
Blood 1988;72(5):1449-55.
1988: Franca Franchi; Armando Tripodi; C Valsecchi; Pier M Mannucci
Functional assays of protein C: comparison of two snake-venom assays with two thrombin assays.
Thrombosis and haemostasis 1988;60(2):145-7.
1988: Marco Cattaneo; J F Mustard; Maria Teresa Canciani; M Richardson; Augusto B Federici; Pier M Mannucci
Conditions influencing the interaction of asialo von Willebrand factor with human platelets--the effects of external ionized calcium concentration and the role of arachidonate pathway.
Thrombosis and haemostasis 1988;60(2):280-8.
1988: Pier M Mannucci; Massimo Colombo
Virucidal treatment of clotting factor concentrates.
Lancet 1988;2(8614):782-5.
1988: A Ghirardini; T Di Paolantonio; G Iacopino; Guglielmo Mariani; R De Biasi; Pier M Mannucci; Alessandro Gringeri
HIV antigen and virus-safety studies.
Lancet 1988;2(8612):690-1.
1988: Marco Cattaneo; A D'Angelo; M T Canciani; Daniela Asti; S Viganò-D'Angelo; Armando Tripodi; Pier M Mannucci
Effect of oral aspirin on plasma levels of vitamin K-dependent clotting factors--studies in healthy volunteers.
Thrombosis and haemostasis 1988;59(3):540.
1988: Barbara Bardoni; Maurizio Sampietro; M Romano; M Crapanzano; Pier M Mannucci; G Camerino
Characterization of a partial deletion of the factor VIII gene in a haemophiliac with inhibitor.
Human genetics 1988;79(1):86-8.
1988: Augusto B Federici; christophe de romeuf; Philip G de Groot; B Samor; Rossana Lombardi; P D'Alessio; Claudine Mazurier; Pier M Mannucci; Jan J Sixma
Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF).
Blood 1988;71(4):947-52.
1988: Pier M Mannucci; Rossana Lombardi; Giancarlo Castaman; J A Dent; A Lattuada; Francesco Rodeghiero; T S Zimmerman
von Willebrand disease "Vicenza" with larger-than-normal (supranormal) von Willebrand factor multimers.
Blood 1988;71(1):65-70.
1987: Pier M Mannucci; D Mari; F I Pareti
Effectiveness of a heated prothrombin complex concentrate in hemophiliacs with inhibitors.
Thrombosis and haemostasis 1987;58(4):1090-1.
1987: Pier M Mannucci; V Vicente; I Alberca; Elisabetta Sacchi; G Longo; A S Harris; A Lindquist
Intravenous and subcutaneous administration of desmopressin (DDAVP) to hemophiliacs: pharmacokinetics and factor VIII responses.
Thrombosis and haemostasis 1987;58(4):1037-9.
1987: M Moia; Pier M Mannucci; L Vizzotto; S Casati; Marco Cattaneo; Claudio Ponticelli
Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin.
Lancet 1987;2(8570):1227-9.
1987: Pier M Mannucci; G Tamaro; G Narchi; G Candotti; Augusto B Federici; D Altieri; Francesco Tedesco
Life-threatening reaction to factor VIII concentrate in a patient with severe von Willebrand disease and alloantibodies to von Willebrand factor.
European journal of haematology 1987;39(5):467-70.
1987: Veena Chantarangkul; Armando Tripodi; Pier M Mannucci
Evaluation of a fully automated centrifugal analyzer for performance of hemostasis tests.
Clinical chemistry 1987;33(10):1888-90.
1987: Pier M Mannucci; Armando Tripodi
Laboratory screening of inherited thrombotic syndromes.
Thrombosis and haemostasis 1987;57(3):247-51.
1987: Pier M Mannucci; M Moia; Paolo Rebulla; D Altieri; Joan Monteagudo; Ricardo Castillo
Correction of the bleeding time in treated patients with severe von Willebrand disease is not solely dependent on the normal multimeric structure of plasma von Willebrand factor.
American journal of hematology 1987;25(1):55-65.
1987: K Schimpf; Pier M Mannucci; W Kreutz; H H Brackmann; Günter Auerswald; N Ciavarella; J Mösseler; V DeRosa; B Kraus; C Brueckmann
Absence of hepatitis after treatment with a pasteurized factor VIII concentrate in patients with hemophilia and no previous transfusions.
The New England journal of medicine 1987;316(15):918-22.
1987: M Cattaneo; C Bevilacqua; A Lecchi; Pier M Mannucci
In vitro and ex vivo effects of indobufen on human platelet aggregation, the release reaction and thromboxane B2 production.
Haemostasis 1987;17(5):293-300.
1986: Augusto B Federici; Pier M Mannucci; R Bader; Rossana Lombardi; A Lattuada
Heterogeneity in type IIB von Willebrand disease: two unrelated cases with no family history and mild abnormalities of ristocetin-induced interaction between von Willebrand factor and platelets.
American journal of hematology 1986;23(4):381-90.
1986: Alessandro R Zanetti; Pier M Mannucci; E Tanzi; G A Moroni; M De Paschale; Massimo Morfini; V Carnelli; M C Tirindelli; R De Biasi; N Ciavarella
Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLV-III-positive patients.
American journal of hematology 1986;23(4):339-45.
1986: M Conti; D Mari; E Conti; M L Muggiasca; Pier M Mannucci
Pregnancy in women with different types of von Willebrand disease.
Obstetrics and gynecology 1986;68(2):282-5.
1986: Pier M Mannucci; Rossana Lombardi; Augusto B Federici; J A Dent; T S Zimmerman; Z M Ruggeri
A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF).
Blood 1986;68(1):269-74.
1986: Paola Verani; G Mariani; Pier M Mannucci; G De Rossi; Loredana Nicoletti; Fausto Titti; E Falcione; D Pasqualetti; M Ammassari; A Gringeri
Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
Journal of medical virology 1986;19(2):143-9.
1985: Alessandro R Zanetti; P Ferroni; M Colombo; Antonietta Cargnel; D Mari; Gianguglielmo Zehender; M G Rumi; A Gringeri; M Ammassari; Pier M Mannucci
Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy.
La Ricerca in clinica e in laboratorio 1985;15(4):357-64.
1985: Pier M Mannucci; Rossana Lombardi; R Bader; L Vianello; Augusto B Federici; S Solinas; Maria Gabriella Mazzucconi; G Mariani
Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor.
Blood 1985;66(4):796-802.
1985: Pier M Mannucci; M Ammassari; A Gringeri; D Geroldi; Alessandro R Zanetti
Anti-LAV and concentrate consumption in Italian hemophiliacs.
Thrombosis and haemostasis 1985;54(2):556.
1985: Pier M Mannucci; M Morfini; L Gatti; D Rafanelli; M Colombo; D Geroldi; M Einarsson; Alessandro R Zanetti
No hepatitis after treatment with a modified factor IX concentrate in previously untreated hemophiliacs.
Annals of internal medicine 1985;103(2):226-7.
1985: Pier M Mannucci; A Gringeri; M Ammassari
Antibodies to AIDS and heated factor VIII.
Lancet 1985;1(8444):1505-6.
1985: Pier M Mannucci; M Vaglini; M Maniezzo; E Magni; Daniela Mari; N Cascinelli
Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinoma.
European journal of cancer & clinical oncology 1985;21(6):681-5.
1984: Pier M Mannucci; A Gringeri; M Ammassari; D Mari
Abnormalities of lymphocyte subsets are correlated with concentrate consumption in asymptomatic Italian hemophiliacs treated with concentrates made from American plasma.
American journal of hematology 1984;17(2):167-76.
1984: S Casati; M Moia; G Graziani; A Cantaluppi; A Citterio; Pier M Mannucci; Claudio Ponticelli
Hemodialysis without anticoagulants: efficiency and hemostatic aspects.
Clinical nephrology 1984;21(2):102-5.
1983: Pier M Mannucci; Rossana Lombardi; F I Pareti; S Solinas; Maria Gabriella Mazzucconi; G Mariani
A variant of von Willebrand's disease characterized by recessive inheritance and missing triplet structure of von Willebrand factor multimers.
Blood 1983;62(5):1000-5.
1983: S Casati; M Moia; Giorgio Graziani; A Cantaluppi; Pier M Mannucci; Claudio Ponticelli
Haemostasis parameters behaviour during haemodialysis without anticoagulants.
Life support systems : the journal of the European Society for Artificial Organs 1983;1 Suppl 1():144-7.